PEB - Pacific Edge Ltd

[Okebw]

It seems to be a point that's regularly bought up so here:

http://www.business.govt.nz/companies/app/ui/pages/companies/1119032/shareholdings

This lists the top 10 holders and is updated fairly regularly. No clue where you'd find the top 50 though.

[Dentie]

Nice bit in the ODT today ...

http://www.odt.co.nz/news/business/311041/rural-gps-likely-favour-new-e-commerce-site

Glad this was cleared up for some professionals...

Reaction from urologists to the new service had been positive so far, Dr Darling said.
There had been concern from some urologists who had misread an earlier statement and thought the results were being sent directly to the patient, rather than the GP.
The results could only be obtained from medical professionals, he said.

[Balance]

It seems to be a point that's regularly bought up so here:

http://www.business.govt.nz/companies/app/ui/pages/companies/1119032/shareholdings

This lists the top 10 holders and is updated fairly regularly. No clue where you'd find the top 50 though.

It is so out of date that it is completely and totally useless.

Compare with the latest :


1
NEW ZEALAND CENTRAL SECURITIES DEPOSITORY LIMITED
58233287


2
K ONE W ONE LIMITED
20286297

3
SUPERLIFE TRUSTEE NOMINEES LIMITED
14623498

4
FNZ CUSTODIANS LIMITED
10422959

5
MASFEN SECURITIES LIMITED
7965326

etc etc

[Okebw]

It is so out of date that it is completely and totally useless.



My bad in that case. The companies registrar has always been accurate when I've checked in the past.

[Dentie]

It is so out of date that it is completely and totally useless.

Compare with the latest :


1
NEW ZEALAND CENTRAL SECURITIES DEPOSITORY LIMITED
58233287


2
K ONE W ONE LIMITED
20286297

3
SUPERLIFE TRUSTEE NOMINEES LIMITED
14623498

4
FNZ CUSTODIANS LIMITED
10422959

5
MASFEN SECURITIES LIMITED
7965326

etc etc

6
"Balance"
?

[Schrodinger]

7
"Mac"

8
"Hancocks"

??

[Balance]

6
"Balance"
?

Haha - if only! 6 has 7.9m shares!

No 100 has 315,000 shares.

[Balance]

The whole discussion about the top 100 shareholders totally bemuses me each time it is raised. The latest one I have seen is for the two weeks prior to 23 July and shows no significant changes - as has been the case for the last 6 months.

If you call the No 1 shareholder, being institutions, increasing their collective shareholding from 45m shares to 58m shares, and Hujlich & others decreasing by several millions as showing no significant changes - then, that's ok!

Oops, NewGuy keeps digging :D

[Mista_Trix]

...That is infinitely more helpful than Balance's silly little games.

As I wrote before, your postings tell more about you....

This crap (from both sides) is getting really boring to read guys.
Play the ball not the man, the rest of us are pretty sick of it - and its doing a great job of clogging up the thread.

[skid]

This crap (from both sides) is getting really boring to read guys.
Play the ball not the man, the rest of us are pretty sick of it - and its doing a great job of clogging up the thread.

Done and dusted:)

[nextbigthing]

This crap (from both sides) is getting really boring to read guys.
Play the ball not the man, the rest of us are pretty sick of it - and its doing a great job of clogging up the thread.

This thread is actually only 10 pages if you cut out all the cr#p. But 70:1 cr#p posts:good posts isn't bad right, right?!

[Whipmoney]

That’s really very low, I always wonder how much they discount for sentiment in creating a ‘price target’. But good on them for having a go and for being brave enough to go first.

I don't think $1.10 is low.. I can no longer be bothered doing the maths but that is a ridiciously high price to sales ratio so I'm not sure why anyone would want to pay so much for such an uncertain sales trajectory.

It may take years to get to 20,000 units let alone the 285k or so that they would need to get to USD $100m in sales. Why pay such a premium for such a high level of risk?


On a side note, i'm not sure why everybody is harping on about institutional investors. Firstly i'm sure NZ institutional investors knowledge of biotech is limited at best. Secondly institutions don't always get it right, either in terms of picks or timing.

[MAC]

If as I understand, the FB valuation at $1.10 assumes a delivery of profitability and $100M in revenues much later than what PEB are presently projecting, then that may well be a fair and conservative approach for FB lay cliental at this juncture, particularly as it’s the first analysts report off the block.

It’s a matter now of tracking progress against a curve.

What it does do though I think black knat, is provide room for positive upside surprises if PEB are on schedule against their goals, or rather not as delayed as FB have set as a benchmark expectation.

I don’t work to P/S ratios, they just mislead, there are other pertinent variables and they are too coarse to be meaningful.

[winner69]

Forbar reckon $1.10, that's good

The soon to be released Edison report (commissioned by a few major investors I hear) will be between $1.50 and $1.70

For what's it worth my DCF valuation after pushing everything out a few years and adding in a few more expenses for this year is still around the $1.00 mark

No news is often good news.

PEB management just getting on with it and drumming up support to make the dream happen

So low 70's still a good entry (sub 70 was better)

Reckon it will be close to a $1.00 by end of August

And don't forget what happens if there a surprise announcement - we must be due for one

[winner69]

And a strong finish to the day bodes well for the rest of this week

Onwards and upwards

[Whipmoney]

If as I understand, the FB valuation at $1.10 assumes a delivery of profitability and $100M in revenues much later than what PEB are presently projecting, then that may well be a fair and conservative approach for FB lay cliental at this juncture, particularly as it’s the first analysts report off the block.

It’s a matter now of tracking progress against a curve.

What it does do though I think black knat, is provide room for positive upside surprises if PEB are on schedule against their goals, or rather not as delayed as FB have set as a benchmark expectation.

I don’t work to P/S ratios, they just mislead, there are other pertinent variables and they are too coarse to be meaningful.

I accept that but there may be far more 'slippage' in sales than even Forbar are expecting, which is relatively commonplace in this industry in which there generally are clear winners and a sea of dead losers.

Presuming it all works out though 70-90c probably isn't a half bad entry :)

[klid]

Forbar have commenced coverage with a price target of $1.10.

Thanks; I was wondering why it did so well today!


I don't think $1.10 is low.. I can no longer be bothered doing the maths but that is a ridiciously high price to sales ratio so I'm not sure why anyone would want to pay so much for such an uncertain sales trajectory.
Is the current price to sales ratio worth mentioning? I don't know that it has a lot of value in terms of it being used as a metric at this stage?

[Balance]

Good one - so now you can see how PEB shareprice could go the RAK way

Careful, W69 - you are going to get accused of being a down ramper soon.

:D

PS. Time to change comparison chart to that of DIL to show how DIL charged upwards 2000% from 40c to $8.00?

[Balance]

Mark my words but a certain animal will be back, waxing lyrical about PEB soon.

:D

Better get back quick as I sense $1.00 coming up before the AGM. :D

[Balance]

You and Forsyth Barr can try and pump PEB all you want, sales are the driver here and until I see WAY more I'm going nowheree near the bull side.

I remember a certain insto called for $6.70 DIL as well after the SP had plummetted. That wasmany, many moons ago. Analyst reports can be very wrong sometimes, and shareholder faith is a VERY hard thing to get back once its gone...

Hardly pumping, Moosie.

Simply alerting a trader like yourself to the change in tone.

Surely as a trader that's what you watch out for, right?

[winner69]

Hardly pumping, Moosie.

Simply alerting a trader like yourself to the change in tone.

Surely as a trader that's what you watch out for, right?

That tone / sentiment has changed in the last day or two eh Bal

Short termers see it as a way to make a buck (maybe not that much but you get what I mean eh) over the next few weeks and no doubt some serious investors are seeing now as a buy opportunity

Yes, the tone of the market is important.

I remember 10 years or so an outfit called Baycorp was trading at 20 times sales. Absolutely ridiculous but some silly Aussie outfit paid a premium to buy it. (There is always a greater fool eh). Maybe current silence from PEB because a few hanging around the place working out how much to pay. I'd take $1.20 at he moment

[Balance]

That tone / sentiment has changed in the last day or two eh Bal

Short termers see it as a way to make a buck (maybe not that much but you get what I mean eh) over the next few weeks and no doubt some serious investors are seeing now as a buy opportunity

Yes, the tone of the market is important.

I remember 10 years or so an outfit called Baycorp was trading at 20 times sales. Absolutely ridiculous but some silly Aussie outfit paid a premium to buy it. (There is always a greater fool eh). Maybe current silence from PEB because a few hanging around the place working out how much to pay. I'd take $1.20 at he moment

I have vowed they cannot have mine for less than $5

[AndyLP]

I would love to see a copy of that ForBarr research if anyone feels like sharing! :)

[winner69]

I would love to see a copy of that ForBarr research if anyone feels like sharing! :)

Sign up / open an account with them - or if you with another broker maybe Forbar does a better job

[barney]

http://www.odt.co.nz/news/business/311150/pacific-edge-positive-speculative-broker

[Schrodinger]

Anyone willing to trust Chelsea with a 2021 prediction lolz. Interesting that a 3rd party has said the goalposts are now 2 years further down the track. In my mind this will increase commercialisation risk due to new tech and copycats. Also note, what in their opinion is causing a delay in successful commercialisation 2 years further out. The time to sell agressively is now while they have a product advantage.

Choose wisely.

[skid]

You guys are reading alot into this considering they (peb) havent really come up with the goods yet--whats changed?
This analylist is pushing the 100mil target out 2 years and is saying aside from being speculative it could fail and be worth nothing--but as you say ,it only takes the SH to be in a buying mood to push up the SP.
In terms of performance,it would be nice to see some mention of them over there in the US.-somewhere

[skid]

Forbar reckon $1.10, that's good

The soon to be released Edison report (commissioned by a few major investors I hear) will be between $1.50 and $1.70

For what's it worth my DCF valuation after pushing everything out a few years and adding in a few more expenses for this year is still around the $1.00 mark

No news is often good news.

PEB management just getting on with it and drumming up support to make the dream happen

So low 70's still a good entry (sub 70 was better)

Reckon it will be close to a $1.00 by end of August

And don't forget what happens if there a surprise announcement - we must be due for one

$1.50-1.70--where did you hear that?

[MAC]

Wouldn't be at all surprised if Edison come in closer to $2 based on company set goals.

They will possibly though base their valuation on specific market research rather than company announced goals as unlike FB they have the specialist biotech sector analysts in the UK and US to do this, let's see.

[goldfish]

Neither would i mac, but it will just show how worthless and bias edison are if they do.

[Leftfield]

Many see Brokers recommendations as the "kiss of death"......only time will tell.

However, nice to see that recent interest in this stock has stopped/slowed the rot in the SP.

[MAC]

Do you really think so goldfish, their website tells us they have 110 analysts covering 700 stocks in 128 countries. It’s not any ones job to fly their flag but they have always seemed to do an adequate job to me, and they actually bother to sit with those companies and provide info to investors that others don’t.

But on what do you base your slander, just curious ?

[goldfish]

Do you really think so goldfish, their website tells us they have 110 analysts covering 700 stocks in 128 countries. It’s not any ones job to fly their flag but they have always seemed to do an adequate job to me, and they actually bother to sit with those companies and provide info to investors that others don’t.

But on what do you base your slander, just curious ?

I base my slander on my own observations of them giving valuations that are way above current or future valuation for every company i have seen them value.
I rate them as i rate morningstar.

[goldfish]

Yes i realise that...it doesnt change my impressions of there valuations though.

[MAC]

Everyone gets a say and view I guess;

Mine would be that I don't think their global reputation is worth any bias or fee that they would ever recieve from a small biotech company in the antipodes. The local brokers have significantly more self interest in tweaking valuations and in creating ‘price targets’.

Valuation, share price and ever evolving risk perceptions are all different things, valuations often seem high or low to some.

“In the short term, the stock market behaves like a voting machine, but in the long term it acts like a weighing machine” – Benjamin Graham

[Balance]

I see Forbar is forecasting around 5,000 tests in 2015.

Mr Chris Swann better has a good answer for his comment about 'tens of thousands of tests' in 2014 at the AGM.

[psychic]

I see Forbar is forecasting around 5,000 tests in 2015.

Mr Chris Swann better has a good answer for his comment about 'tens of thousands of tests' in 2014 at the AGM.

Do they provide much in the way of rationale behind this or their revenue forecasts Balance?

[winner69]

$1.50-1.70--where did you hear that?

Sounds like I heard wrong as MAC says closer to $2

[psychic]

Is that a bot nibbling away on the buy side this morning? Interesting.......

[winner69]

Ever seen a sell or reduce recommendation with a lower than current SP valuation.from Edison?

I rest my case.

I don't think they say buy/accumulate either

[Balance]

Do they provide much in the way of rationale behind this or their revenue forecasts Balance?

It's an initiating research report by Forbar so they are 'starting afresh' so to speak.

It is really a question for PEB and Chris Swann to answer.

Especially when Mr Swann sold a heap of shares ($550,000) worth and Mr Darling too after making that very bullish comments.

[winner69]

It's an initiating research report by Forbar so they are 'starting afresh' so to speak.

It is really a question for PEB and Chris Swann to answer.

Especially when Mr Swann sold a heap of shares ($550,000) worth and Mr Darling too after making that very bullish comments.

Balance - would that sale of Swanns mean he has got all his investment in PEB back?

[Harvey Specter]

I see Forbar is forecasting around 5,000 tests in 2015.

Mr Chris Swann better has a good answer for his comment about 'tens of thousands of tests' in 2014 at the AGM.Havent they (silently) rejected that statement was ever made to the ODT. Or has he made it again?

[psychic]

Yup sure. Don't want to drag all that up again. It's been done to death.

I am more interested in just how they forecast clinical uptake and their arguments behind this. Do they present anything that we have not discussed on this thread that might give us insight?

Or is this all just best guess also?

Thanks

[Balance]

Yup sure. Don't want to drag all that up again. It's been done to death.

I am more interested in just how they forecast clinical uptake and their arguments behind this. Do they present anything that we have not discussed on this thread that might give us insight?

Or is this all just best guess also?

Thanks

Now is the time to question Mr Chris Swann and PEB, as Forbar has issued the Report only after PEB has vetted it for reasonableness.

There has been no official explanation or retraction from PEB and for a company which relies a great deal on market credibility, that is smply not good enough.

A complaint to the FMA and NZX is in the offing if PEB and Mr Swann do not front up with a reasonable explanation at the AGM.

[Balance]

Balance - would that sale of Swanns mean he has got all his investment in PEB back?

Like Masfen, more than his original investment back.

Good on them, I say - except in the case of Mr Swann, he owes all those who bought PEB on the back of his bullish comments an explanation.

[MAC]

http://www.odt.co.nz/news/business/311150/pacific-edge-positive-speculative-broker

Thanks Barney,

There is a fair and reasonable takeaway to be had;

Forsyth Barr I think are reluctant to go to full valuation straight away based on PEB announced goals, and have instead elected to provide a very conservative initiating report with a $1.10 valuation based on PEB being two years late, two years within a five year plan is really quite conservative.

It does though provide a lot of room for positive upside ‘suprises’ if PEB do track on time or don’t track as far behind as FB have set as an initiating basis. It will be interesting to see FB's valuation in 12 months from now.

A fair warning on risk for their lay cliental too I think, if you were such considering buying PEB rather than TEL because of the high upside then the relative risks do need to be clear. It’s about risk/reward positions after all.

[Balance]

Thanks Barney,

There is a fair and reasonable takeaway to be had;

Forsyth Barr I think are reluctant to go to full valuation straight away based on PEB announced goals, and have instead elected to provide a very conservative initiating report with a $1.10 valuation based on PEB being two years late, two years within a five year plan is really quite conservative.

It does though provide a lot of room for positive upside ‘suprises’ if PEB do track on time or don’t track as far behind as FB have set as an initiating basis. It will be interesting to see FB's valuation in 12 months from now.

A fair warning on risk for their lay cliental too I think, if you were such considering buying PEB rather than TEL because of the high upside then the relative risks do need to be clear. It’s about risk/reward positions after all.

Forbar's actual valuation is 96c.

Price target is however $1.10, based upon sentiment getting positive as the year progresses. That is, they expect investors will mark the stock up as numbers firm.

At this stage, I would say investors would pay between 72c to 77c to be in the stock until the AGM - ie. 20% to 25% discount to Forbar's valuation.

What PEB says at the AGM and how they answer some questions will be interesting. It is now a NZX50 company and the institutional shareholders are going to be more exacting with their queries.

[Beagle]

I had my cystoscopy this morning and all good and the Urologist said she could see clear signs of the old infection despite this occurring on 1 June, 2 months ago that lead to the bleeding.
Cytology was also good, as were blood tests, renal ultrasound, bowel screening test and 2 x prostate checks. No further sign of haematuria has occurred since 1 June so its now crystal clear it was just a bad bladder infection and I'm all good :) In the circumstances as its clear what the cause of the original haematuria was there is no point taking a CX bladder test.

I did have an interesting discussion with the Urologist about CX Bladder that might interest you guys.
After talking with a number of medical professionals about this process it was a relief to finally talk to someone who had an in-depth understanding of the benefits of it and it helped break the ice and keep my mind off what is a relatively unpleasant procedure, (cystoscopy).
My Urologist was involved in the original 100 person trial done by the Waitemata DHB and was very impressed with the CX Bladder test and its results and she added that they were very pleasant people to work with.
She went on to explain that its an issue of bulk funding. It costs them about $1,000 to do a cystoscopy but their costs don't go down if they also order up a CX Bladder test and at present from what she told me it isn't funded by the Government.

She went on to explain that whilst my procedure showed clear signs of the original cause of the haematuria if they had any doubts they would send me for a CT scan as the next procedure.
I asked her whether she thought it would take off in N.Z. ? Not unless its publically funded but she thought the prospects in the U.S. were better but results would take time to eventuate.

How much time and does that make the company worth its market capitalisation today...who would know ?
1.4 million views on this thread and over 10,000 posts says one thing to me...plenty of people looking for answers.
My closing thoughts from the coal face are this. The medical field is very, very slow to change. My Urologist told me a cystoscopy is the GOLD standard and that won't change anytime soon.
She went on to say if the day comes when its publically funded here and they can say with a 98% probability that a CX Bladder test replaces a Cystoscopy then they would encourage patients to use it instead of the other in a certain age group provided they accepted the risks, (I gathered a waiver would be required).

Its a good product, how much time it takes to get commercial traction and whether that's fairly reflected in the current market cap, who would really know ?
I think the stock is "highly speculative". It doesn't fit my investment profile but that's not to say it isn't worth a small punt within a well diversified investment portfolio. Good luck to all holders.

Yours faithfully
Lab Rat.

[psychic]

Thanks Roger, and great to hear you are all clear.

I'm actually encouraged by this. We don't seem to even use the established biomarkers in NZ so "world first" leap to Cxbladder will not be made here.

The plan is US adoption first. And for my money this is now a lot less speculative than others think.

[Balance]

Thanks Roger, and great to hear you are all clear.

I'm actually encouraged by this. We don't seem to even use the established biomarkers in NZ so "world first" leap to Cxbladder will not be made here.

The plan is US adoption first. And for my money this is now a lot less speculative than others think.

IT is definitely less speculative than it was 2 years ago but PEB must now show real traction - something it must address at the AGM. The honeymoon is over.

[Slam dunk]

My closing thoughts from the coal face are this. The medical field is very, very slow to change. My Urologist told me a cystoscopy is the GOLD standard and that won't change anytime soon.
She went on to say if the day comes when its publically funded here and they can say with a 98% probability that a CX Bladder test replaces a Cystoscopy then they would encourage patients to use it instead of the other in a certain age group provided they accepted the risks, (I gathered a waiver would be required).

Its a good product, how much time it takes to get commercial traction and whether that's fairly reflected in the current market cap, who would really know ?
I think the stock is "highly speculative". It doesn't fit my investment profile but that's not to say it isn't worth a small punt within a well diversified investment portfolio. Good luck to all holders.

Yours faithfully
Lab Rat.

Roger - I'm really glad to hear you're going to be ok! That's excellent news! Regarding your analysis though - you frame the question as whether or not CxBladder will take over from cystoscopy. I didn't think that was PEB's primary objective/intention. I thought Cxbladder is intended to be more of an adjunct to cystoscopy, replacing cytology.

[psychic]

Roger - I'm really glad to hear you're going to be ok! That's excellent news! Regarding your analysis though - you frame the question as whether or not CxBladder will take over from cystoscopy. I didn't think that was PEB's primary objective/intention. I thought Cxbladder is intended to be more of an adjunct to cystoscopy, replacing cytology.

Correct SD, but the long term goal (see AHRQ) is to replace cystoscopies altogether with perhaps a collective of non invasive tests

http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1941

[Beagle]

Roger - I'm really glad to hear you're going to be ok! That's excellent news! Regarding your analysis though - you frame the question as whether or not CxBladder will take over from cystoscopy. I didn't think that was PEB's primary objective/intention. I thought Cxbladder is intended to be more of an adjunct to cystoscopy, replacing cytology.

Thanks mate...yeah that's how I understood it but the way the urologist was talking it seems cytology is here to stay so unless the Govt fund CX bladder tests here instead of cytology it appears the investigative methodology I went through will remain the status quo in N.Z. for the foreseeable future. It would be interesting to know the difference in costs between the 3 stage urine sample cytology and a one-off CX Bladder test.
Who knows maybe the N.Z. govt will wake up and smell the coffee after realising the cost difference isn't much ?

One thing this last 2 months has taught me, Nobody knows how long they've got...now where did I put that Jaguar brochure :)

[MAC]

Correct SD, but the long term goal (see AHRQ) is to replace cystoscopies altogether with perhaps a collective of non invasive tests

http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1941

I though the goal of Cxbladder was to replace the aging NPM22 tech and to become an adjunct to the gold standard, perhaps I read that wrong several times ?

Agree though, the outcome of the AHRQ could be profound, they’ve limited the study to the existing urine based tests presently selling into the market including Cxbladder, and Cxbladder clinically outperforms the others.

If the AHRQ deem as an outcome that the gold standard, or part therein, should be replaced by urine based biomarker tests, that $100M revenues 10% market share goal may seem really quite understated looking back.

[psychic]

I though the goal of Cxbladder was to replace the aging NPM22 tech and to become an adjunct to the gold standard, perhaps I read that wrong several times ?

Agree though, the outcome of the AHRQ could be profound, they’ve limited the study to the existing urine based tests presently selling into the market including Cxbladder, and Cxbladder clinically outperforms the others.

If the AHRQ deem as an outcome that the gold standard, or part therein, should be replaced by urine based biomarker tests, that $100M revenues 10% market share goal may seem really quite understated looking back.

Exactly MAC.
There are many other tests out there, but this study has been confined to the existing FDA approved tests AND Cxbladder only.

On the replace or adjunct issue, it is clear that while biomarkers may have the potential to replace cystoscopy, it will be a lot easier to slip the test alongside for a few years first.....

[Hawkeye]

I may have dropped the ball on this one, but have you lot seen
http://www.nbr.co.nz/article/analyst-optimistic-about-nzx-listed-cancer-test-maker-db-p-160036

[NT001]

Looks like there's a big buy order for PEB at 76c

[skid]

Thanks for your insights Roger--one thing for sure-by the end of this journey we will know alot more about selling into the medical field,one way or another (as apposed to something like XRO)

[klid]

I may have dropped the ball on this one, but have you lot seen
http://www.nbr.co.nz/article/analyst-optimistic-about-nzx-listed-cancer-test-maker-db-p-160036
I quit my stupid job where I had free access to NBR. Please could someone post it? And there is now a large SELL overhang for 76c 😊😊:)

[Harvey Specter]

I quit my stupid job where I had free access to NBR. Please could someone post it? And there is now a large SELL overhang for 76c 😊😊:)Similar article on Stuff from memory (or was it the link to ODT above). Have left work for the day so locked out till the morning.

[klid]

Edison research has an update on some interesting competition this morning.:).
Biolight's Celldetect looks like it is going down the same path as cxBladder but a long way behind I would think.
Cheers
Minerbarejet
http://www.edisoninvestmentresearch.com/research/report/biolight-life-sciences-inv1

Sensitivity 88% specificity 68%.

[Whipmoney]

http://www.edisoninvestmentresearch.com/research/report/biolight-life-sciences-inv1

Sensitivity 88% specificity 68%.

Sometimes I wonder if these companies are even aware of whats already out in the market.. I.e is a case medical scientists blindly following through with commercialisation their biomarker research.

Still an attractive market cap for the potential upside. Not sure how well resourced they are to roll it out though!

[Slam dunk]

"Only" a 76M NIS market cap ($25M NZD). Roll up roll up for the next ten bagger :p

Nevermind the fact that the Tel Aviv exchange could get blown up.

[klid]

yes, will have to do better than that
Cant seem to get my tablet to do the link thingy. Thanks Klid.
Can do it on the computer but it means a climb down to level 8, a wait for startup, 25minutes updating Windows 97:)

Maaaate. I spent a while figuring out how to do it on my S5. Had to highlight some txt in the box first and then got the paste option.

seeminly this coy is focusing on other stuff too... some eye product at a quick glance?

What I am pleased to see (very pleased) over the last few days is PEB diverging from the XRO trend a bit. Hope that isn't due to temporary things e.g. forbar and continues.

[winner69]

If you in Christchurch and want to play uni students again this could be interesting free lecture

What if ....cancer screening can cause harm as well as benefit

https://www.eventbrite.co.nz/e/what-ifcancer-screening-can-cause-harm-as-well-as-benefit-tickets-12146351063

Been some onteresting What if lectures over the years.

Usually putter up on YouTube post event

[TimmyTP]

If you in Christchurch and want to play uni students again this could be interesting free lecture

What if ....cancer screening can cause harm as well as benefit

https://www.eventbrite.co.nz/e/what-ifcancer-screening-can-cause-harm-as-well-as-benefit-tickets-12146351063

Been some onteresting What if lectures over the years.

Usually putter up on YouTube post event
That is an interesting topic, but I suppose it will be a re-hash of numerous other studies that raise concern over false positives, harm from unnecessary biopsies etc.
I don't think Pacific Edge's tests are really targetted at screening programmes though, are they?

[geo]

Hi Mac.

What did you think of Forsyth Barr analyst Chelsea Leadbetter outperform rating on Peb?

[MAC]

Hi Geo, I posted my thoughts amongst those of others at the time, generally I think FB has done well to summarise the business position, and recognising it’s not easy to be the one to go first, I think Chelsea has done a suburb job in researching and documenting Pacific Edge. Brave and very conservative perhaps just because it is the first one, and many have been twitching for something.

I’m going to elaborate just because it’s a Sunday afternoon;

FB do seem to have been quite conservative in their modelling and have effectively adjusted their valuation downward heavily for risk by allowing two extra years for Pacific Edge to meet their $100M goal, they have been conservative also in applying a highish WACC at 13.3% and a lowish PG at 2.0%.

Pacific Edge have jumped the big risk hurdles that most commonly hinder biotech companies, these being successful clinical trials, achieving regulatory approvals, raising capital, and in entering the market place with a product superior to what’s incumbent and with good value propositions. I would have placed WACC at 11.75% or there about's. PWC determined a WACC of 12.1% for Pacific Edge some twelve months ago, a lot of water has passed under the bridge since then.

This conservative approach allows FB head room for further valuation upgrades if PEB prove to be on schedule, or not as far behind as FB have adjusted their model for. IMHO we may see valuation upgrades from FB progressively now over the next couple of years if Pacific Edge do even just an adequate job at commercialisation.

My personal view is that I would prefer the local brokers did not follow this practice, it does seem to be more endemic in NZ than elsewhere.

A valuation is just that and investors are capable of laying out both valuations and the risks on the table in assessing a risk/reward position, most don’t require FB to tweak the numbers for them, it can cloud the picture unless you read the entire 30 page report to assess what’s been tweaked.

It was good to hear that 12 sales staff will have been appointed by, well about now, and the number will be taken to 20 in the medium term.

Let's see what the AGM now brings in terms of outlook.

[Balance]

The PEB beat-up brigade has now moved onto DIL, I see.

Please come back to PEB as the sp is up too much - 20% when the beat up brigade screamed 'out out' as a Rakon is in the offing!

[Balance]

Ain't no RAK, but 20 % is usually how far the dead cats bounce after falling off cliffs ;)

Really?

The last dead cat bounce I saw went up several thousand %tage and turned out to be a tiger.

It is not Snakk though!

[Schrodinger]

Really?

The last dead cat bounce I saw went up several thousand %tage and turned out to be a tiger.

It is not Snakk though!

When is the next sales report due?

I must admit I like the DIL business model better than PEB as they have commercialised but we will wait and see.

[Balance]

When is the next sales report due?

I must admit I like the DIL business model better than PEB as they have commercialised but we will wait and see.

AGM is when directors and management are going to front up on how things are tracking.

[Tsuba]

The PEB beat-up brigade has now moved onto DIL, I see.

Please come back to PEB as the sp is up too much - 20% when the beat up brigade screamed 'out out' as a Rakon is in the offing!

Yes it has got a bit boring since the gold standard Rakon chart overlay isn't quite matching up at the moment.

[winner69]

Yes it has got a bit boring since the gold standard Rakon chart overlay isn't quite matching up at the moment.

PEB still tracking Rakon Tsuba

When it comes to market sentiment and investor behaviour things unfold slowly.

Be patient and optimistic .....there's hope yet ....Rakon one of the stsrs of the NZX today

[winner69]

?...............that makes me cynical and untrusting of the general market loooooong beforr I grow old...

Moosie, does that untrusting go beyond the markets? To business in general? To politics? To the world in general?

Interested to hear

[psychic]

I see the big boys @ LNG.AX are also dumping their stock at the giddy heights after a slew of announcements with no/little revenue and massive promises, just like PEB. They also have their fanboys/cheerleaders/apologists, just like PEB. I can see history repeating itself with the big boys taking care of themselves while the little guy with no insider views gets shafted. It hasn't hapoened yet, but it forms a very real pattern that makes me cynical and untrusting of the general market loooooong beforr I grow old...

Sheesh
Hey Moosie, what are you seriously invested in - long term. I mean - real skin in the game? (ie something you are passionate about and have genuinely drilled down on - you know, like you did with DIL...as it tanked.. or maybe MBE?)

I'd like to p"ss on your convictions in absolute ignorance as you do- just for a change. I promise I won't research it or bother to understand where it is at, I'll just give you the benefit of some free twaddle.

You clearly think we need it.

[skid]

Before you get to harsh,go back and read the DIL thread (from way back)--Moosie was you guys,back then.
In reality this share could go either way--Its not a done deal any more as marketing has come in to the equation.
If only we could be a fly on the wall in the boardroom.

[Dentie]

I don't fall in love with stocks anymore. They are just a vehicle for making money to me now because of the lack of faith I have in the broader reachs of humanity (who are very, VERY greedy). Once you take the emotion out of stocks and realise it's only money it becomes a lot easier to play the game.

The last time I loved a stock it cost me 45% of my not insignificant capital I had saved up in my short time on this earth. I have vowed to never be so blind again.

There is no sadder sight than seeing an injured moose wandering around the forest ... almost as if the wounds are too deep to bother licking any more...

It is your highlighted text above Moosie that makes it very nervous for me to put trust in TA. The MACD is heading up over the signal line, with a good divergence....the DMI+ is about to cross the DMI- and is above the 25 mark....the RSI is poking its nose above the 50 line....the double bottom occurred a wee while back...the last candle has burst up through the trend line...the volume is exploding...and the momentum has begun....then I invest my life savings.....THEN THE GREEEEEDY BUGGERS SELL. Why bother?

[NT001]

Would this guy be a useful addition to PEB's board?

<Wellington investment company Rangatira announced at its annual meeting yesterday that the board has appointed Phil Veal as its chief executive. Veal will move with his family from his current base in New York City to Wellington to take up the role.Since 2006, he has been a Partner of middle-market investment and advisory firm Growfire in New York. His role at Growfire included being strategic advisor to Nasdaq-listed technology company Cognizant, Chair of DialedIn, a Californian provider of cloud-based mobile sales software, and an investor and advisor to a range of early stage businesses across sectors as diverse as medical devices, consumer goods and wine.>

[Copper]

I see the big boys @ LNG.AX are also dumping their stock at the giddy heights after a slew of announcements with no/little revenue and massive promises, just like PEB. They also have their fanboys/cheerleaders/apologists, just like PEB. I can see history repeating itself with the big boys taking care of themselves while the little guy with no
insider views gets shafted. It hasn't hapoened yet, but it forms a very real pattern that makes me cynical and untrusting of the general market loooooong beforr I grow old...
I find this post interesting....Do I recall a few weeks back or even a month I was agreeing with you that LNG was an interesting stock and you had got in at let's say 75 and you may have sold at let's say again 130/150. A good trade ....the mentioning of selling by those close to the Company wouldn't appear out of the ordinary at the three dollars plus. Your post seems a bit of Gooord we blew this one. Am I on the right track. I was hoping you may have still had a modest holding..Kind regards....

[Schrodinger]

Would this guy be a useful addition to PEB's board?

<Wellington investment company Rangatira announced at its annual meeting yesterday that the board has appointed Phil Veal as its chief executive. Veal will move with his family from his current base in New York City to Wellington to take up the role.Since 2006, he has been a Partner of middle-market investment and advisory firm Growfire in New York. His role at Growfire included being strategic advisor to Nasdaq-listed technology company Cognizant, Chair of DialedIn, a Californian provider of cloud-based mobile sales software, and an investor and advisor to a range of early stage businesses across sectors as diverse as medical devices, consumer goods and wine.>

If your selling in the USA any type of connections are useful. Not sure about his USA experience but it might be useful to PEB. Would prefer a rock solid USA experienced director to open doors.

[winner69]

PEB can't be near lows yet

Zero Commission yet to make an offer ....55 cents?

[Xerof]

The two guys behind Zero are not a great advertisement for the Broking community in general. I thought politicians were the least trusted in the eyes of the public.........

[psychic]

Well, good riddance to whoever it was needing to dump that lot today...

[Whipmoney]

So, Balance, what you going to name the cat?

Springsteen?


PS: Is anyone else getting weird formatting for Sharetrader. I'm getting scroll bars inside each post :confused:?

[Balance]

So, Balance, what you going to name the cat?

Haha - last time I looked, it is still well above the 62c so you are suggesting that there's an invisible floor above the floor where the cat supposedly died?

[Balance]

That fall from $1.75 hurt her pretty badly. Maybe call her Mrs Limpsalot? Sure hope she doesn't end up like Old Yeller...

Haha - when it falls like Snakk relentlessly from one level to another lower level and all shareholders save those who got in via 'connections' are bleeding money, then it will be time to listen for the 'meow'?

[Balance]

I first bought PEB @ 33 cents. May consider it again if it reaches that level... ;)

I would not buy it if it reaches 25 cents - this stock is either going to head towards $5 or 5c. Pure and simple.

[skid]

Patience my friend....Patience........patience.....ah thats better....patience...Dang!......Patience.......... .......

[Xerof]

Chairman Chris Swann, said: “On behalf of the Board, I would like to thank Colin for the significant contribution he has made in bringing the Company to the point where it is today with its first cancer diagnostic system, Cxbladder, acclaimed by clinicians in the United States and other markets as leading technology in the accurate diagnosis of bladder cancer.
“Pacific Edge is now successfully commercialising the Cxbladder technology in the world’s largest health market, the US, and looking to further developments of the Cxbladder system. In line with this, the Board has identified a number of commercialisation skills and capabilities that would be of value to the Company. We are in discussions with several candidates and we hope to make an announcement on appointment of new directors in the near future.”


Note to PEB

Would our chairman put some numbers on a slide at the AGM to enable shareholders to gain some insight into the degree of acclamation and level of success please?

[klid]

"“Pacific Edge is now successfully commercialising the Cxbladder technology in the world’s largest health market, the US."

How can they say that? Far out. What defines success? I suppose we should see the price rocket up right now. Or are they just saying stuff for the hell of it. I am really starting to wonder. Don't know about voting to reelect Swan as a director... maybe they need a bit of a kick? Maybe not, just mentioning it.

[Balance]

"“Pacific Edge is now successfully commercialising the Cxbladder technology in the world’s largest health market, the US."

How can they say that? Far out. What defines success? I suppose we should see the price rocket up right now. Or are they just saying stuff for the hell of it. I am really starting to wonder. Don't know about voting to reelect Swan as a director... maybe they need a bit of a kick? Maybe not, just mentioning it.

Tens of thousands of tests in 2014 - Mr Chris Swann better have a good answer to his assertion, especially since he sold shares after making that comment.

[Xerof]

Tens of thousands of tests in 2014 - Mr Chris Swann better have a good answer to his assertion, especially since he sold shares after making that comment.

hence my earlier request

i am looking for a pleasant surprise tbh, but would like be able to get a clearer read on how to interpret his wording

[MAC]

Despite a few on this thread having previously held unrealistic expectations for high sales levels, before sales staff were even hired and trained, and user programmes actually rolled over.

If as I understand they now have circa 12 sales staff on board and are ramping up to 20 in the near term then we may well see a little traction up to the end of the September HY reporting period and preliminary in November. Sales staff at the end of the last reporting period was around 4 if I recall correctly, sales managers and strategic sales folk probably at that time.

I’m not expecting a sales update at the AGM, other companies don’t provide YTD figures, why should PEB.

Good to see some further international exp coming into the organisation especially PEDusa.

[benjitara]

"“Pacific Edge is now successfully commercialising the Cxbladder technology in the world’s largest health market, the US."

How can they say that? Far out. What defines success? I suppose we should see the price rocket up right now. Or are they just saying stuff for the hell of it. I am really starting to wonder. Don't know about voting to reelect Swan as a director... maybe they need a bit of a kick? Maybe not, just mentioning it.

They didn't say successfully selling cxbladder, commercialisation is simply getting the product to market, they have done that.

[skid]

So williams and Nogales were around long before the last sales figures announcement.
Im sure both the 69cent goonies and the 1.75 goonies are hoping they have made some headway.

[skid]

There are also investors who were put off when the company came through with dismal sales results (like you when you first saw them)Now Im not going to go so far as to call you a goonie(that would be bad taste)but I would venture to say that some of those who have taken a hit on those results,have every reason to be cautious.
They didnt have the luxury of having bought in at the beginning when it was cheap(although your patience and research on the product is commendable) But do you may not know much about the marketing side of things.
I stand by my opinion of the importance of a joint venture--I believe ,if and when the champagne corks are popped-that will be a big part of the reason.
Ive never doubted that CX is a great product--but even great products dont sell themselves.
You have alot of skin in the game,and you can ignore it if you like,but perhaps others who are starting from scratch should give it some consideration.-(with all due respect)

[MAC]

There are investors in Pacific Edge who have real confidence that the company is on track to complete the commercialisation of its stated vision from the prospectus of 2002; and, I'm one of those investors. I have been invested and followed the company since the IPO.

There are investors who have been put off the company; or, investors who have their confidence tested by personality types (the goonies) akin to crude, loud mouthed drunken bloody yobbos at a party gobbing off a constant bombardment of megalomaniacal, paranoiac, half-arsed bulls#!t. Ignore them, their opinions are not worth a knob of goat s#!t - for example, won't make it without an American joint venture partner crap etc. etc.

Ha, yep, classic, perhaps a day in a goonies life must go something like this;

Tailgate, run reds, cut in front on the way to work, stab a colleague in the back, log into sharetrader and crap on peoples hard earned investments, initiate some life destroying office gossip, log into sharetrader and attempt to scare some newbies, home time, kick the cat, whip the kids, beat the wife and sleep soundly knowing a successful day as a goonie has been had.

[blackcap]

Ha, yep, classic, perhaps a day in a goonies life must go something like this;

log into sharetrader and attempt to scare some newbies, .

Or attempt to save newbies some hard earned capital maybe :)

[MAC]

I don't recall Pacific Edge having ever provided annualised guidance, it can't therefore be possible to state that they had a dismal result then unless one just has an agenda to trash a company for some form of self gratification, or has done so little research that they expected miracles even before sales folk had been hired and trained and user programmes rolled over.

Pacific Edge seem to be doing just fine to me, looking forward to the AGM and some positive updates on the commercialisation sequence.

[skid]

Ha, yep, classic, perhaps a day in a goonies life must go something like this;

Tailgate, run reds, cut in front on the way to work, stab a colleague in the back, log into sharetrader and crap on peoples hard earned investments, initiate some life destroying office gossip, log into sharetrader and attempt to scare some newbies, home time, kick the cat, whip the kids, beat the wife and sleep soundly knowing a successful day as a goonie has been had.

Do you really seriously think the posts on here are going to cause a major change in the SP?-Maybe some small fluctuations,but in the end ,its going to be PEB that determines that(at least at this point ,now that the hype is over.)
OK some of the posts have been a bit crude and Im not going to waste time defending those who posted them,but some of them probably took a sizable hit so they are not going to be happy campers.
Lets face it,part of the blame lies with those ,who in their enthusiasm about the company and product,perhaps influenced some of those newbies you speak of ,to buy in at the lofty heights and then tumble down into the abyss--So they were most likely pretty pi--d off--Now your blaming them for slagging the company(as if its their fault) sounds a bit rich to me.
I tried to do some digging and see if I could find a sign that they were making some sort of headway in the US market and came up with zilch-no mention of them-even on sites that should have,like the American Cancer Inst.
Thats information people should know in terms of what kind of success they are having at marketing the product--thats not slagging -its questioning. Others could have searched and maybe would have found a mention of them,whiuch would be good.
Theres a number of reputation comments(when they were anonymous)contained in your last post.
I could make up some scenarios as well to post..but Im not going to stoop to it.

But Dude ,nobodies listening to me---remember?

[skid]

Most of my purchases skid was when the company was raising money to progress the development & commercialisation of the bladder cancer test, I have been involved in 8 capital raisings in total, so they were all very very very risky early on and each investment was based on conversation with the principals and investigation of the company. Nothing has changed. I did not make money trading PEB shares.

However, there are some Share Trader posters whose only intention is to piss people off with the crap they post on this; and, believe it or not other threads about PEB, I’m fed up with it and if they want to play that game then bring it on, I will take this thread back. Post reasoned argument and we can debate it.

The game is only starting with PEB, they are not judged successful only when they hit their self-imposed $100M target, they will be successful well below that.

Im not questioning your purchases,far from it.
Im not supporting those whos only intention is to piss people off.
I may have done that occasionally in an attempt at humor-but not intentionally.
I do question--Its alot harder to get a handle on how they are promoting the product,then it is to evaluate the product itself.
It may well be a slow road(as you say)
I think the problem arises when posters try to gauge against the backdrop of the fireworks the past year has brought,both up and down.
Its understandable there has been some vindictive feelings on both sides of the board--there has been alot of changes involving alot of dosh.

[skid]

Hi skid, the intended purpose of Share Trader has been hijacked on the Pacific Edge thread particularly. I post information when it is relevant that is either new, or from various websites I have catalogued over the years for those that want to read it; and, so do others, that is what it is all about. There has been a prevalence lately for a general piss take that has been instigated by that bloody Moose goon in particular and a few followers that do not have his smarts; and, they have been suckered. The thread still is about Pacific Edge but it needs to be claimed back.


Fair Enough

[MAC]

Volatility can cause some folk some anguish, but at the end of the day the volatility is not due to anything Pacific Edge have done or have not done. They are more or less, within the bounds of reasonableness, very much where they told us they would be so.

For every short term trader that has a win another just had a loss, it’s the law of market averages, but again not anything due to Pacific Edge. Buy low and sell high, or buy high and sell low, Pacific Edge didn’t make them do it.

It may just simply be that some take an opportunity to be vindictive slandering losers as an outlet for their frustrations because an anonymous forum presents as an opportunity to do so. Shows poor character I reckon.

For long term investors like Hancock’s who have no interest in the short term share price it probably is quite frustrating to see the next envious, jealous or frustrated individual unfairly trash the company. Particularly so when having invested so much time into understanding the product and people involved.

[skid]

I think it is fair game to question ( not slander) how the company (the caretaker of a great product)is promoting the product.
That is not the same thing as slandering the product (it was a brilliant piece of work by the scientists involved)
Everyone who posts regularly has an interest on the short term share price--It may not be the priority,but if you check it ,you have an interest.
Some of the volatility is due to what Pacific edge has done(a few statements and director buying)even if it wasnt intentional,but for the most part I agree that PEB will carry on,on the path they have chosen.
Whether they have chosen the right strategy is yet to be seen ,but its not a given IMO.
It may go down further and then make a slow recovery,or do the opposite.
I only hope that if they find they have made the wrong choices,that the company still survives, as some day I may need the test.

[nextbigthing]

I haven't watched Game of Thrones yet but from I hear it's similar to this thread

[Minerbarejet]

Moosie reckons its World Of Warcraft,

[Blue Horseshoe]

More like candy crush, things looking sweet, then getting crushed.

[Harvey Specter]

I haven't watched Game of Thrones yet but from I hear it's similar to this threadI reason the NZX is like GoT - as soon as you get a favourite, it gets killed. My portfolio is littered with the likes of PEB, DIL, chu.

[Schrodinger]

More like candy crush, things looking sweet, then getting crushed.

Good forward thinking by PEB:

Pacific Edge is now successfully commercialising the Cxbladder technology in the world's largest health market, the US, and looking to further developments of the Cxbladder system. In line with this, the Board has identified a number of commercialisation skills and capabilities that would be of value to the Company. We are in discussions with several candidates and we hope to make an announcement on appointment of new directors in the near future."

This is an important step and I hope they get someone with some clout. Would of preferred this 3 years ago before the big cash burn in the US but they are starting to think correctly.

[nextbigthing]

I reason the NZX is like GoT - as soon as you get a favourite, it gets killed. My portfolio is littered with the likes of PEB, DIL, chu.

Wait for the wedding.....

(Haven't seen it but I've heard)

[skid]

Good forward thinking by PEB:

Pacific Edge is now successfully commercialising the Cxbladder technology in the world's largest health market, the US, and looking to further developments of the Cxbladder system. In line with this, the Board has identified a number of commercialisation skills and capabilities that would be of value to the Company. We are in discussions with several candidates and we hope to make an announcement on appointment of new directors in the near future."

This is an important step and I hope they get someone with some clout. Would of preferred this 3 years ago before the big cash burn in the US but they are starting to think correctly.

Now that what Im talkin bout--Did they elaborate on those commercialization skills?
If they announce they have someone with clout on board then from an FA point of view-that would be a good time to perhaps jump back in,even though sales may not have progressed that much ,up to that point.(provided they are worth their salt)
Until then though,its just gambling, until some other announcement comes along or the next lot of sales figures come through.
The fact that they associate the commercialization skills with a ''candidate'' to me highlights the need for a partner or at least a director with that ''clout''
How do we know they are worth their salt? well,if it is an established corp(like johnson and johnson)we know they have the goods --If its Jon Doe,I guess thats where the research comes in--who was he involved with before.his success, etc. etc.

[skid]

I reason the NZX is like GoT - as soon as you get a favourite, it gets killed. My portfolio is littered with the likes of PEB, DIL, chu.

You've probably got a point there HS--If it had'nt been for all the hype-PEB maybe would have slowly risen from the 50cent to the 69cent where it is now and everyone would more of less be happy.

[MAC]

It’s not actually new news, these directorship appointments have been in place since last year.

There is actually a lot of exp behind the scenes beyond the director’s appointments if one actually bothers to look before just knocking the company for the hell of it, the CV of Jack Atchason Vice President of Sales for instance is an interesting read as is Jackie Walkers if you have a lazy Saturday afternoon, then there is the CV’s of the strategic sales manager(s) too, also interesting.

Experience galore !

https://www.linkedin.com/pub/jack-atchason/8/883/66a

https://www.linkedin.com/profile/view?id=4147712&authType=NAME_SEARCH&authToken=xheK&locale=en_US&srchid=1972364901407549533075&srchindex=1&srchtotal=1&trk=vsrp_people_res_name&trkInfo=VSRPsearchId%3A1972364901407549533075%2CVS RPtargetId%3A4147712%2CVSRPcmpt%3Aprimary

[Schrodinger]

It’s not actually new news, these directorship appointments have been in place since last year.

There is actually a lot of exp behind the scenes beyond the director’s appointments if one actually bothers to look before just knocking the company for the hell of it, the CV of Jack Atchason Vice President of Sales for instance is an interesting read as is Jackie Walkers if you have a lazy Saturday afternoon, then there is the CV’s of the strategic sales manager(s) too, also interesting.

Experience galore !

https://www.linkedin.com/pub/jack-atchason/8/883/66a

https://www.linkedin.com/profile/view?id=4147712&authType=NAME_SEARCH&authToken=xheK&locale=en_US&srchid=1972364901407549533075&srchindex=1&srchtotal=1&trk=vsrp_people_res_name&trkInfo=VSRPsearchId%3A1972364901407549533075%2CVS RPtargetId%3A4147712%2CVSRPcmpt%3Aprimary

Yes I was aware these two are not new but I assume the comments on the 8th about looking for more is genuine or is that referring to 2013 as well?

[Minerbarejet]

Good forward thinking by PEB:

Pacific Edge is now successfully commercialising the Cxbladder technology in the world's largest health market, the US, and looking to further developments of the Cxbladder system. In line with this, the Board has identified a number of commercialisation skills and capabilities that would be of value to the Company. We are in discussions with several candidates and we hope to make an announcement on appointment of new directors in the near future."

This is an important step and I hope they get someone with some clout. Would of preferred this 3 years ago before the big cash burn in the US but they are starting to think correctly.
Would you perhaps care to elaborate on your definition of someone with clout for us? Is this some magical "bossy boots" person who can open any door providing easy access and passage through a minefield of red tape, telling the various agencies, urologists and medical professionals to get their act together and to do it now or preferably yesterday? One should perhaps consider that the clouter, if she exists, was at one stage without clout and was a cloutee or on the receiving end of clout. They probably earned this "badge of honour" through "successful" business dealings probably accompanied by the the odd kneecapping.
Your posts give the appearance of your being familiar with the requirements for success in the US.
Did you have someone in mind, maybe?

[skid]

Would you perhaps care to elaborate on your definition of someone with clout for us? Is this some magical "bossy boots" person who can open any door providing easy access and passage through a minefield of red tape, telling the various agencies, urologists and medical professionals to get their act together and to do it now or preferably yesterday? One should perhaps consider that the clouter, if she exists, was at one stage without clout and was a cloutee or on the receiving end of clout. They probably earned this "badge of honour" through "successful" business dealings probably accompanied by the the odd kneecapping.
Your posts give the appearance of your being familiar with the requirements for success in the US.
Did you have someone in mind, maybe?

Someone with ''clout'' in the US medical industry (and alot of others as well) is someone who is not only familiar with the science and product ,but has connections with those who make decisions up high in the industry.
Thats how things work in the states--Its a system of lobbying governments to get the politicians you sponsor to make decisions in your favor.--Its not a coincidence that the past vice president ,Don Cheney also sat on the board of Halliburten (who got contracts to build military bases that were created because of decisions that the government made to put them there)
That sort of thing can happen on a lower level which would be more relevant in this case.
The ideal director with clout would be on speaking terms with those directly involved in decisions that weould make CX bladder more visible--Once the product is recognized-then many health professionals would find out the things you already know (about CX) and the ones that are not to stuck in their ways may consider changing and giving it a go.
As some already know-I feel it is far better to have a company that already has market share on board,but barring that, I suppose a director with clout is the next best thing.
You dont just throw that type of product out there in the states and expect it to fly off the shelves .
This is one company with one product(so far)in a world of companys with a whole stable of medical products,including the perks to go along with them.

Im not in the business..but i have talked to those who are familiar with the requirements for success in the US (medical industry) and it goes along these lines.---this is not a slag--it is a recipe for perhaps turning things around for PEB

No-I dont have anyone in mind--That is the job of those who are bringing home six figure salarys and Im keen to reinvest in this company once I see that they have started earning it.

[BigBob]

Someone with ''clout'' in the US medical industry (and alot of others as well) is someone who is not only familiar with the science and product ,but has connections with those who make decisions up high in the industry.
Thats how things work in the states--Its a system of lobbying governments to get the politicians you sponsor to make decisions in your favor.--Its not a coincidence that the past vice president ,Don Cheney also sat on the board of Halliburten (who got contracts to build military bases that were created because of decisions that the government made to put them there)
That sort of thing can happen on a lower level which would be more relevant in this case.
The ideal director with clout would be on speaking terms with those directly involved in decisions that weould make CX bladder more visible--Once the product is recognized-then many health professionals would find out the things you already know (about CX) and the ones that are not to stuck in their ways may consider changing and giving it a go.
As some already know-I feel it is far better to have a company that already has market share on board,but barring that, I suppose a director with clout is the next best thing.
You dont just throw that type of product out there in the states and expect it to fly off the shelves .
This is one company with one product(so far)in a world of companys with a whole stable of medical products,including the perks to go along with them.

Im not in the business..but i have talked to those who are familiar with the requirements for success in the US (medical industry) and it goes along these lines.---this is not a slag--it is a recipe for perhaps turning things around for PEB

No-I dont have anyone in mind--That is the job of those who are bringing home six figure salarys and Im keen to reinvest in this company once I see that they have started earning it.

Dick...! not Don... Dick...!

Dick Cheney...

[Minerbarejet]

Someone with ''clout'' in the US medical industry (and alot of others as well) is someone who is not only familiar with the science and product ,but has connections with those who make decisions up high in the industry.
Thats how things work in the states--Its a system of lobbying governments to get the politicians you sponsor to make decisions in your favor.--Its not a coincidence that the past vice president ,Don Cheney also sat on the board of Halliburten (who got contracts to build military bases that were created because of decisions that the government made to put them there)
That sort of thing can happen on a lower level which would be more relevant in this case.
The ideal director with clout would be on speaking terms with those directly involved in decisions that weould make CX bladder more visible--Once the product is recognized-then many health professionals would find out the things you already know (about CX) and the ones that are not to stuck in their ways may consider changing and giving it a go.
As some already know-I feel it is far better to have a company that already has market share on board,but barring that, I suppose a director with clout is the next best thing.
You dont just throw that type of product out there in the states and expect it to fly off the shelves .
This is one company with one product(so far)in a world of companys with a whole stable of medical products,including the perks to go along with them.

Im not in the business..but i have talked to those who are familiar with the requirements for success in the US (medical industry) and it goes along these lines.---this is not a slag--it is a recipe for perhaps turning things around for PEB

No-I dont have anyone in mind--That is the job of those who are bringing home six figure salarys and Im keen to reinvest in this company once I see that they have started earning it.
Ok now, my questions were directed at Schrodinger but since you have answered Skid you have first dibbs and yes I realise you brought the subject up
First sentence. Would you say all products that are successful in the US are that way because of someone knowing someone high up? Are there any cases of success without this requirement?
Would you say there are a lot of people out there acutely familiar with PEB's particular line of endeavour?
Seems to me the chances of finding someone are getting a bit remote already.
You might look at someone like Jackie Walker who----- lo and behold, we have already, ----has the credentials but does she have the connections. We shall see.
The next bit of your post smacks of corruption and backhanders which I am not about to debate here being unfamiliar with the subject.
Flying off the shelves?? Dont think anyone is expecting that given the planning and expertise that has gone into getting this organisation under way. They are expecting a gradual build up with expotential growth in the US with the revenues allowing them to expand into Asia eventually. Dont forget all the other planning and guidelines that are going on for other products in the pipeline and in other markets. Plus, and this is a biggie as far as Im concerned, the conduit of innovation from Otago is open directly to PEB.
Who knows what might be just around the corner.
As far as giving it a go- this is where the sales teams are poised to sign up the urologists after they have been able to assess the benefits through the free tests handed out. They will exploring all opportunities there.
Would suggest that 69 cents is not a bad entry point as far as Im concerned but who listens to me anyway.
Only the dog and if it hasnt got dinner as the subject matter she goes back to sleep.
Think Ill have another rum:)

[MAC]

Perhaps the level of corruption one perceives in the world Miner is commensurate with their own applied morality.

This is Bruce Nogales appointment announcement from 18 months ago, seems to have an entirely appropriate skill set and exp to oversee the expanding team in Hershey.

https://www.nzx.com/companies/PEB/announcements/234038

We should expect good things from good people, it will be interesting to hear from Jackie Walker at the AGM if she attends.

[skid]

Dont mistake people with connections with the ear of those that make decisions as corruption--If you think of the (ok)Dick Cheney example as corruption,well,Im saying thats how things work in the states,(many times)
People or organizations lobby the government to get what they want--That includes large campaign donations to have a ''friend''in the Gov.--It sounds lousy (and it is)but its legal over there.
If you think that corruption and backhanders is not common,I would suggest you do some more reaserch--You could start with whats called the ''revolving door policy''
Im not condoning that particular angle,(as Mac is suggesting) but its an example of how things work alot of the time over there (at least in high places)and to ignore it is naive in my opinion
Thats why someone with connections can get things done much quicker.
Those there now may be fine for going ''door to door'' but it could be a slow road and dont forget there are others with ''clout''--power--who are not going to take competition lightly--
You can attack the messenger if you like,but its something to consider.--just sayin

[Dentie]

Dont mistake people with connections with the ear of those that make decisions as corruption--If you think of the (ok)Dick Cheney example as corruption,well,Im saying thats how things work in the states,(many times)
People or organizations lobby the government to get what they want--That includes large campaign donations to have a ''friend''in the Gov.--It sounds lousy (and it is)but its legal over there.
If you think that corruption and backhanders is not common,I would suggest you do some more reaserch--You could start with whats called the ''revolving door policy''
Im not condoning that particular angle,(as Mac is suggesting) but its an example of how things work alot of the time over there (at least in high places)and to ignore it is naive in my opinion
Thats why someone with connections can get things done much quicker.
Those there now may be fine for going ''door to door'' but it could be a slow road and dont forget there are others with ''clout''--power--who are not going to take competition lightly--
You can attack the messenger if you like,but its something to consider.--just sayin

Thanks for the education on the rules and how the US plays the game Skid. My naivity is surpassed only by my shock that they haven't lobbied already.

If it's legal...(just like compulsory tipping is!!)...then what are we waiting for? I think PEB should do another capital raising - say USD$50m - and give it to Jackie to spread it amongst those that need to be lobbied. She should make sure she gets a receipt though. If PEB can't raise the USD$50m...then just oil up the printer .... "quantitive easing" will give us what we need (that appears to be legal too).

[Minerbarejet]

Dont mistake people with connections with the ear of those that make decisions as corruption--If you think of the (ok)Dick Cheney example as corruption,well,Im saying thats how things work in the states,(many times)
People or organizations lobby the government to get what they want--That includes large campaign donations to have a ''friend''in the Gov.--It sounds lousy (and it is)but its legal over there.
If you think that corruption and backhanders is not common,I would suggest you do some more reaserch--You could start with whats called the ''revolving door policy''
Im not condoning that particular angle,(as Mac is suggesting) but its an example of how things work alot of the time over there (at least in high places)and to ignore it is naive in my opinion
Thats why someone with connections can get things done much quicker.
Those there now may be fine for going ''door to door'' but it could be a slow road and dont forget there are others with ''clout''--power--who are not going to take competition lightly--
You can attack the messenger if you like,but its something to consider.--just sayin
Are you going to the AGM? If you are then it would seem like a marvellous opportunity to point out to management where they are going wrong and advise them accordingly. I shall be watching the webcast with considerable interest.

[winner69]

Thanks for the education on the rules and how the US plays the game Skid. My naivity is surpassed only by my shock that they haven't lobbied already.

If it's legal...(just like compulsory tipping is!!)...then what are we waiting for? I think PEB should do another capital raising - say USD$50m - and give it to Jackie to spread it amongst those that need to be lobbied. She should make sure she gets a receipt though. If PEB can't raise the USD$50m...then just oil up the printer .... "quantitive easing" will give us what we need (that appears to be legal too).

Dentie, should do a bit of reading on the lobby industry in the US.

As long as avoid James Kuntsler you should get a pretty good idea of what goes on. Kuntsler tells you how corrupt and evil the system is but not for the mainstream to read.

[Dentie]

Dentie, should do a bit of reading on the lobby industry in the US.

As long as avoid James Kuntsler you should get a pretty good idea of what goes on. Kuntsler tells you how corrupt and evil the system is but not for the mainstream to read.

Cheers W69. If it is like this to do business in the world's chief economy - why bother? Why not just focus on the rest of the world.

[winner69]

Cheers W69. If it is like this to do business in the world's chief economy - why bother? Why not just focus on the rest of the world.

It's not just business dentie ...it's politics

But one day the world will become a decent place

But back to PEB - I take heart from Balance's comment that PEB are aware of what's needed and have put the right people on the ground in the US already

[Minerbarejet]

Does anyone believe that PEB management and executive have made a foray into the American Market without first weighing up the risks involved, including the political atmosphere, lobbying, the red tape and bureaucratic nightmares?
Does anyone think that they have not taken on board good advice on these matters well before this point and are just doing a Kiwi No 8 wire, she'll be right, fix it as you go scenario?
It would seem the ideal move by people with "clout" protecting their patch would have been to ensure the Lab in Hershey didnt open.
However that is not the case, Pacific Edge has been welcomed with open arms, in fact so welcome that Jack Atchason, Director of Business Development at the Hershey Centre for Applied Research has joined PEB .

[winner69]

Does anyone believe that PEB management and executive have made a foray into the American Market without first weighing up the risks involved, including the political atmosphere, lobbying, the red tape and bureaucratic nightmares?
Does anyone think that they have not taken on board good advice on these matters well before this point and are just doing a Kiwi No 8 wire, she'll be right, fix it as you go scenario?
It would seem the ideal move by people with "clout" protecting their patch would have been to ensure the Lab in Hershey didnt open.
However that is not the case, Pacific Edge has been welcomed with open arms, in fact so welcome that Jack Atchason, Director of Business Development at the Hershey Centre for Applied Research has joined PEB .

Agree

Balance has reassured us a few times over the years that shortcomings in the US have been addressed. Thanks Balance

The good guy always wins

[winner69]

My god... the PEB bulls are sounding desperate to put their point across with ignorant post like this.
If you did your homework on the health care market in the US you would no stopping a lab of this sort opening is virtually impossible.
The single biggest threat to PEB is large pharmaceutical companies throwing their weight around.. this includes companies that are marketing products that compete with cx bladder.
These companies have billion $ revenues and are pushing a huge arrange of products.
Also can posters stop pushing the first starter advantage for PEB...... Bio markers for bladder cancer have been commercially available and used for over a decade in the US.
You don't have to look far to see PEB's foray's into other countries have been a complete flop... what makes you think the US is going to be any different.

Still reckon best outcome now is $1.50 offer from somebody early next year

[Xerof]

Is anyone going to question PEB Board on where CMS coverage is at? Last we heard they were saying August 2014. Well, we're half way through already and not a peep or whisper. I have a feeling this one was put up on over enthusiasm and will be mussed by a wide mark.

I'm expecting something in mid to late-2015 now.

keep up moosie - end of year was the latest update from Darlings Auckland presso.

[Minerbarejet]

My god... the PEB bulls are sounding desperate to put their point across with ignorant post like this.
If you did your homework on the health care market in the US you would no stopping a lab of this sort opening is virtually impossible.
The single biggest threat to PEB is large pharmaceutical companies throwing their weight around.. this includes companies that are marketing products that compete with cx bladder.
These companies have billion $ revenues and are pushing a huge arrange of products.
Also can posters stop pushing the first starter advantage for PEB...... Bio markers for bladder cancer have been commercially available and used for over a decade in the US.
You don't have to look far to see PEB's foray's, with cx bladder, into other countries have been a complete flop... where is the proof that make's you think the US is going to be any different.
Gidday Snap, hows it going, thought you had gone away somewhere.
Shall we do a deal, we'll stop pushing first starter advantage if you stop pushing big pharma disadvantage.
Cheers
Miner

[skid]

Cheers W69. If it is like this to do business in the world's chief economy - why bother? Why not just focus on the rest of the world.

The lobbying by corporations etc is a fact Dents,but I was just making the point that the American market is a tough place--The large Pharma co.s lobby,but I was'nt suggesting that PEB could or would lobby the Gov.--they are simply to small--I was talking more along the lines of a director with connections-(thats not a bad thing)

[skid]

Are you going to the AGM? If you are then it would seem like a marvellous opportunity to point out to management where they are going wrong and advise them accordingly. I shall be watching the webcast with considerable interest.

No Ill be in Thailand,but Im sure the AGM will be interesting and Im keen to hear about it--do you honestly think that because of my opinion that they could have possibly misjudged the American market and would do well to bring on board someone with a foot in the door--that Im trying to step up and run the company?

People in the business have have told me their views on the American medical market and how it works--maybe they are wrong,but I am taking it on board until either there is a jump in sales from their current strategy or they do get a partner or the type of director that can get some traction.
This whole thing started with me when I tried to find some mention of PEB in America.
Its a great product so why doesnt it even get a mention in places like the American Cancer Inst?
Doesnt that concern you? If it doesnt -go back and have another look at the SP chart.

[Minerbarejet]

No Ill be in Thailand,but Im sure the AGM will be interesting and Im keen to hear about it--do you honestly think that because of my opinion that they could have possibly misjudged the American market and would do well to bring on board someone with a foot in the door--that Im trying to step up and run the company?

People in the business have have told me their views on the American medical market and how it works--maybe they are wrong,but I am taking it on board until either there is a jump in sales from their current strategy or they do get a partner or the type of director that can get some traction.
This whole thing started with me when I tried to find some mention of PEB in America.
Its a great product so why doesnt it even get a mention in places like the American Cancer Inst?
Doesnt that concern you? If it doesnt -go back and have another look at the SP chart. I suspect the current share price has been affected more by the large number of IPO offerings in this tiny market than by any presumed lack of "clout" from PEB gained from a subdued initial sales report. By the looks of things some of the money that went to these IPO's from traders selling PEB is now tied up in loss making situations and is unlikely to return to procure PEB shares in the immediate future.
Well thats bad luck you wont be there to at least make the enquiry regarding this matter -
I did not suggest that you were trying to step up to run the company.
I was merely suggesting that if you feel that strongly about your opinion you could perhaps take it up with PEB themselves and express your concerns. Their reply would be of interest to everyone I'm sure.

[blackcap]

I suspect the current share price has been affected more by the large number of IPO offerings in this tiny market than by any presumed lack of "clout" from PEB gained from a subdued initial sales report. By the looks of things some of the money that went to these IPO's from traders selling PEB is now tied up in loss making situations and is unlikely to return to procure PEB shares in the immediate future.

I doubt your statement very much. Why should it have affected the PEB shareprice and not other stock's shareprices?

[NT001]

I suspect the current share price has been affected more by the large number of IPO offerings in this tiny market than by any presumed lack of "clout" from PEB

I'd think that's probably right, Miner. The IPOs must have hoovered quite a bit of cash, and where did it come from? Mostly not from investors selling blue chips, I would think. Some traders perceiving no immediate surge in the PEB SP would be cashing up (same with ATM?) to try to stag these tech IPOs and possibly come back if there are signs of upward movement. Analysts were predicting this some time back.

[blackcap]

mate, don't bring that science mumbo jumbo into it.

My apologies to all sharetraders who felt affronted. I will consider myself reprimanded :)


In all seriousness though, there does seem to be an element of "clutching at straws" going on in a few of the posts when the market starts to turn.

[klid]

Is anyone going to question PEB Board on where CMS coverage is at? Last we heard they were saying August 2014. Well, we're half way through already and not a peep or whisper. I have a feeling this one was put up on over enthusiasm and will be mussed by a wide mark.

I'm expecting something in mid to late-2015 now.
Probably the most important thing I can think of. I think about this quite a lot.

Question: why the **** can we not see announcements before 27 Feb on this site:
https://www.nzx.com/markets/NZSX/securities/PEB/announcements
Being the official site I am rather surprised. Is there somewhere reliable and preferably official such as NZX... one can go to see historical announcements?

Anyway, the reason I ask this, is I wanted to elude to some quotes, which from memory go something like this...

(in reference to Medicare/Medicaid)... "may take up to a year to complete", almost a year ago.

So yes, either a very pleasing announcement to come very shortly or a big "oops we said some **** that wasn't quite right..." which would beg the question - what else did they say that hasn't / isn't going to come to fruition.

:)

[barney]

Given that there are so many " smoke and mirror " conspiracy theorists and posters who doubt the managements ability on this thread, it will be interesting to see how many make an appearance at the annual meeting to put their concerns directly to the people running the company. My guess is there won't be many, if any. But post the meeting they will all be back on the thread with the same old stuff.

Sigh. Who would run a public company.

[couta1]

I won't be going to the AGM but will be voting against Chris Swann being reelected but For all the other resolutions all the noise in the world on here won't move me to selling, I'm in for the 5 year haul as I am with all my stocks running good sized losses. At the end of 5 years well see how many of them including Peb are still at a loss and re evaluate. Once I set my mind to something that's it until I see the Goal of a given company is unachievable and I believe Peb can achieve what they set out to do as I do with Xro.

[skid]

Given that there are so many " smoke and mirror " conspiracy theorists and posters who doubt the managements ability on this thread, it will be interesting to see how many make an appearance at the annual meeting to put their concerns directly to the people running the company. My guess is there won't be many, if any. But post the meeting they will all be back on the thread with the same old stuff.

Sigh. Who would run a public company.

Im assuming you will be there --Does asking the question I was alluding to label you as a doubter of managements skills?

Or do you want to find out as much of what is going on as you can.

If your really dead set against my questions--then dont ask-and you will be sure not to get an answer.

I only hope they give a few details on questions that are on SH minds.--like the number of commercialization skills and capabilities that would be of value to the company (what are they?)

[Carpenterjoe]

Give it five-ten-twenty-fifty years, med students would be laughing why would you ever stick that camera up there, just piss in the pot.

But hey, old dogs and new tricks,

Some people will never understand patience and new tricks

[barleeni]

Wow, you can send emails? Amazing. Agama you couldn't even find to most basic information in the simplest financial statements I've ever seen, yet you seem to consider yourself the oracle. I may have sent one regrettable email, but have sold nearly a million dollars of my consulting time over the last 18 months, so obviously I get it right most of the time.

I guess everything looks like a brain fart when you don't even understand the basics

Do we all have to measure our dicks from now on or is it just you NewGuy?

[Meister]

There are actually more pertinent and strategic questions to be asked; and, these usually arise during the presentations or the social conversations afterwards. Going to the meeting with redundant questions generated by brain farts posted on this thread does not enlighten the average Pacific Edge investor. So I for one will not be asking any of the questions that have been raised here for sure!

I will however be voting to re-elect Chris Swann and David Band as Directors and will support the election of Chief Executive Officer David Darling as an Executive Director.

Hancocks I am also genuinely interested in what questions you are thinking of asking. I support PEB, but even you were surprised by the lack of sales, and even you were taking in by Chris Swanns rather ambitious statement regarding expected sales. We know it takes time for things to happen, but you said yourself you would be doubting the 5 year plan if they didn't have 5000ish sales. You were even hoping for 10,000+. Will you be voicing any concerns over the apparent breakdown and 'pushing-back' of the 5 year plan?

Also, please stop attacking each other. Lets keep this thread on topic.

[barney]

Im assuming you will be there --Does asking the question I was alluding to label you as a doubter of managements skills?

Or do you want to find out as much of what is going on as you can.

If your really dead set against my questions--then dont ask-and you will be sure not to get an answer.

I only hope they give a few details on questions that are on SH minds.--like the number of commercialization skills and capabilities that would be of value to the company (what are they?)

I'm not sure if I'll get to the meeting or not. I hope to. Have attended the last three and it's very worthwhile.

My point is really that if people have so much critisism of the company why don't they front up and ask the questions. That's what annual meetings are for. Some shareholders are going to vote against the re-election of the chairman and other board members, which is fine. It's their right. But would you not front up and put to the board members your concerns or questions. I suspect most of this goes back to the fact that a lot of people seem to have purchased shares on the basis of a one line apparent quote in a newspaper article late last year, at a time when the market was going crazy. If that's the case then they need to review how they make investment decisions because it's nuts.

[blackcap]

Wow, that was really insulting to pretty much everyone on here. Questions are there to be asked HC, not to follow the leader blindly into the abyss (that's for Dictatorships).

I used to value your opinion pretty highly. Never blocked anyone before but pretty close to it right now.

This thread is here to discuss, negative or positive. If you don't like it/can't handle it/getting emotional about it, please take a break abd concentrate on other things in life. It's not yours or anyone elses baby.

Please, think before you speak like this again...

Well said Moosie

[MAC]

Perceptions are just that and PEB did not provide annualised FY14 guidance for reasons that they articulated really quite well at the last AGM. If people held a perception of greater FY14 sales than was physically possible it is their own misinterpretation that should be held to account.

There have been some very good achievements by PEB this last year, new patents achieved, first commercial cxbladder sales in the US, a successful capital raising, the sign up of four network providers, user programme completion in NZ and in the US, associations formed with the HIH, a strategic framework for 4 to 6 cxbladder products announced, application of cxbladder to upper urinary tract cancer diagnosis, a very experienced sales team formed in Hershey, CLIA accreditation achieved for the NZ lab, and of course winner of the NZ supreme innovator award.

It would seem to me that the company has achieved a lot and some acknowledgement of that is due at the AGM. There has been very little turnover in the top 100 shareholder list a sign that the overwhelming majority of shareholders are thus contented.

We should look forward to receiving an outlook for next year and an equally successful year, but yes the 2015 financial year should be more about sales traction and progress now, let’s see.

[MAC]

I totally agree with you, but maybe not the first line (we were led up the garden path a bit with Swann, hence the backlash!).

The company does deserve to be congratulated. Now it's time to start pumping out sales. Hopefully you (and maybe I) can congratulate them at later AGMs for this!

I don’t know Moosie, everybody has a unique way of analysing and some have more business exp than others to draw on. That now infamous quote, whether it was actually said or was not said;

“The Pennsylvania lab has the capacity to process 260,000 tests a year and Mr Swann is confident the company will processing ''several tens of thousands of tests'' next year.” (http://www.odt.co.nz/news/business/286676/pacific-edge-business)

I’ve always interpreted that as this present calendar year, others may interpret it as sales to the FY15 financial year reporting. Either way we will not know if they have achieved what was published until May 2015 when the preliminary results are due.

If individuals anticipated 10,000+ sales to FY14 from such comments, then I guess firstly, they cannot read the words “next” and “tests”, and secondly they need to do more investment research, a company cannot substantively sell without first hiring a sales force.

My view is that 10,000+ tests is entirely probable by FY15, I would always as an investor hope that we get some numerical guidance from this AGM but don’t expect it for the same reasons as last year.

[winner69]

Mac said little turnover in the top 100 shareholders ....good support

What % of the 319m shares do the top 100 own

Just curious to get a feel for how much the traders are trading.

Since Jan 1 this year annualised numbers of shares traded is 150m

So if top 100 own say 80% and little movement (except MR Swanns little foray) does that mean the other shares are churning 2 to 3 times a year. Or just a stupid way of looking at it.

[Minerbarejet]

Would it not be a good idea to wait and see what explanations are forthcoming from Messrs Swann and Darling before passing judgement on anything or anyone?
Presumably this will be given some kind of airing prior to the vote at the meeting, however postal voters would have to take their chances.
Very pleased to hear that Jackie Walker is supposed to attend. I doubt that she would be there only as an observer. Would hope that some decent guidance is presented by somebody actually on the front line.

(Miner ducks back under the parapet)

[MAC]

I'm not sure if I'll get to the meeting or not. I hope to. Have attended the last three and it's very worthwhile.

My point is really that if people have so much critisism of the company why don't they front up and ask the questions. That's what annual meetings are for. Some shareholders are going to vote against the re-election of the chairman and other board members, which is fine. It's their right. But would you not front up and put to the board members your concerns or questions. I suspect most of this goes back to the fact that a lot of people seem to have purchased shares on the basis of a one line apparent quote in a newspaper article late last year, at a time when the market was going crazy. If that's the case then they need to review how they make investment decisions because it's nuts.

I’d agree with that and add that I think Swan, Darling and Walker have performed very well, there is much outside their control and a lot of market variables, and that’s entirely why they have appropriately provided a five year goal and not shorter term guidance.

I don’t begrudge directors selling shares in this instance, if Chris Swan and David Darling held those shares for circa ten years and wished to sell a few to renovate the house when the share price first rose to full valuation for the first time, then good on them. Very well deserved indeed after close to a decade of effort and hard work.

[skid]

The AGM will be interesting Im sure ,either by whats said or what isnt said.
I only hope its not just a ''business as usual'' and we have an exciting future.

'' In line with this, the Board has identified a number of commercialisation skills and capabilities that would be of value to the Company''---surely it would be fair to ask for a bit of elaboration on that statement.

Would anyone have any objections to asking if the American market is proving any more difficult than first anticipated(in relation to the first statement)? Or would that hurt their feelings?

Im just geographically to far to attend,(and I m not sure I would even be allowed as Im not a SH any more)so i guess it comes down to whether anyone else who can go ,thinks these items are worth bringing up --(or is it better to just shut up and not know)
Of course they may clarify all and that would be good.
Lets hope there will be solid information to discuss--vagueness and rhetoric only make our discussions more difficult.

disc. In terms of not being a SH any more ,I am waiting to get a better feel where they are going and whether that 5 year plan is not nore like a 10 year plan.

[hilskin]

"Interim results will be announced on Tuesday 26 August with interim report available to shareholders by the end of September."

I think that was meant for the wynyard group thread.

[Minerbarejet]

Do we all have to measure our dicks from now on or is it just you NewGuy?Seems like thats about the long and the short of it.
Some people go to any lengths.:)

[JBmurc]

What % of the 319m shares do the top 100 own

Just curious to get a feel for how much the traders are trading.



A mate has a major position I remember he was up near on a mill in a week on the big spike ,,,tried talking him into selling least half at the time but he's in the for the long haul ...really believe's they have a bright future ...just about aways the top 20 invest for the long term

[nextbigthing]

Seems like thats about the long and the short of it.
Some people go to any lengths.:)

I'm not sure you appreciate the size of the problem

[barney]

Some recent appointments.

http://www.linkedin.com/pub/mary-mathe/62/8a7/304?trk=pub-pbmap

http://www.linkedin.com/pub/mark-wysocki/1b/17/909?trk=pub-pbmap

[Goldstein]

Some recent appointments.

http://www.linkedin.com/pub/mary-mathe/62/8a7/304?trk=pub-pbmap

http://www.linkedin.com/pub/mark-wysocki/1b/17/909?trk=pub-pbmap

Nice one Barney. Those two will be wondering why they are now getting their profile viewed by so many dodgy looking punters from NZ. I'll be interested to hear any comments from those going to the AGM. I've been pretty much kicked out of the NZX by stop-losses recently. I've still got PEB on my radar.

[NT001]

What % of the 319m shares do the top 100 own? Just curious to get a feel for how much the traders are trading.

I have been assuming you really can't tell who the top 100 shareholders are because quite a few of them probably have their shares hidden in some of those big custodial trusts. Or am I wrong? I was looking at the top-100 list posted on the ATM thread, and some friends who I know are up around the million mark aren't listed.

[False Profit]

"Interim results will be announced on Tuesday 26 August with interim report available to shareholders by the end of September."

I think that was meant for the wynyard group thread.

Yep - Sorry guys / gals. My beaver was too eager. post deleted.

FP

[Minerbarejet]

Baffling isnt it. Just got a google alert for Pacific Edge Diagnostics which put me on page 1 of this thread which was quite some time ago. What am I supposed to do - read the whole lot again????????

[psychic]

Baffling isnt it. Just got a google alert for Pacific Edge Diagnostics which put me on page 1 of this thread which was quite some time ago. What am I supposed to do - read the whole lot again????????

:0
When you have finished that Miner, read this and let me know what you think...

http://www.raps.org/Regulatory-Focus/News/2014/08/01/19934/In-Major-Shift-FDA-to-Regulate-Lab-Developed-Tests-as-Normal-Devices/

Some interesting parallels might be drawn PEB / Exact Sciences.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409021.htm

http://www.businessweek.com/news/2014-08-11/exact-sciences-wins-u-dot-s-dot-approval-for-colon-cancer-test

[AndyLP]

:0
When you have finished that Miner, read this and let me know what you think...

http://www.raps.org/Regulatory-Focus/News/2014/08/01/19934/In-Major-Shift-FDA-to-Regulate-Lab-Developed-Tests-as-Normal-Devices/

Some interesting parallels might be drawn PEB / Exact Sciences.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409021.htm

http://www.businessweek.com/news/2014-08-11/exact-sciences-wins-u-dot-s-dot-approval-for-colon-cancer-test


Really interesting links Psychic thanks for posting.

Many parallels here including

- Designed to be used as an adjunt to gold standard
- Similar specificity and sensitivity
- Uses DNA assays (albeit with a haemoglobin test as part of cologuard as well)
- Its a test to be done at least in some instances AT HOME

On this last point, I discovered that one difference with cxBladder is that Cologuard must be ordered by the patient's doctor.

Overview of some sciency stuff for Cologuard - http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/UCM390229.pdf

Would be great if PEB could get this sort of coverage.
Really looks like CMS is open to fully covering bio marker tests, but at the same time, seems like the FDA is asserting itself on Lab Developed Tests (LDTs) that previously didn't require FDA approval, it other words cxBladder.

[Minerbarejet]

Can probably come up with a decent analysis late 2023 or early 2024. :)

Initial inspection tends towards it being the answer to what has happened to CMS approval.
All bogged down in a quagmire of red tape, validations, approvals and approval of approvals
Mind you there is a plethora of new tests, devices, coming along in streams from all sorts of origins.
They will have to speed things up a bit or they will be swamped trying to validate everything.

PEB's test is for prognosis on colorectal, not diagnosis as I understand it.
Cheers

[skid]

Really interesting links Psychic thanks for posting.

Many parallels here including

- Designed to be used as an adjunt to gold standard
- Similar specificity and sensitivity
- Uses DNA assays (albeit with a haemoglobin test as part of cologuard as well)
- Its a test to be done at least in some instances AT HOME

On this last point, I discovered that one difference with cxBladder is that Cologuard must be ordered by the patient's doctor.

Overview of some sciency stuff for Cologuard - http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/UCM390229.pdf

Would be great if PEB could get this sort of coverage.
Really looks like CMS is open to fully covering bio marker tests, but at the same time, seems like the FDA is asserting itself on Lab Developed Tests (LDTs) that previously didn't require FDA approval, it other words cxBladder.

The FDA approved CX Bladder test for bladder cancer also--so why the heck isnt anyone reporting it

[psychic]

Can probably come up with a decent analysis late 2023 or early 2024. :)

Initial inspection tends towards it being the answer to what has happened to CMS approval.
All bogged down in a quagmire of red tape, validations, approvals and approval of approvals
Mind you there is a plethora of new tests, devices, coming along in streams from all sorts of origins.
They will have to speed things up a bit or they will be swamped trying to validate everything.

PEB's test is for prognosis on colorectal, not diagnosis as I understand it.
Cheers

lol, agree with all that. Read it, nodded off. reasoned better others to interpret, and so posted and happily shuffled off to do easier things.

Suspect there may be a few issues in there that might contribute to our understanding of just where we might be at re CMS etc, and with the AGM coming up, perhaps worth drilling down on. I haven't the time right now but will hopefully have a closer look later this week.

Thanks Andy for reading and kicking comments off.

For tonight, quite happy to see Exact Sciences - a one trick pony (?) - has a mcap of $1.4b now with this CMS approval.

Makes you think huh...

[psychic]

The FDA approved CX Bladder test for bladder cancer also--so why the heck isnt anyone reporting it

No, this is something else you have totally misunderstood I think Skid

[Minerbarejet]

The FDA approved CX Bladder test for bladder cancer also--so why the heck isnt anyone reporting itGo to the FDA website and use the search engine for cxBladder - any luck?
Think the goalposts are being shifted with this and we will have to wait for final positioning by FDA. It looks as if there is an attempt to get everything under the fda umbrella .Full Cms approval would follow in quick succession by the sound of whats happened with Exact.
Some of the warnings with using the kit are a bit weird.
Possible hand strain opening and closing the lid on the box?
What are they using, Gorilla Glue? Guess they dont want to come unstuck.:)

[skid]

maybe so..but I have certainly not misunderstood that nothing has been said about CX on any of the cancer or medical sites Ive been searching in the US--Have you had any better luck?

[skid]

Go to the FDA website and use the search engine for cxBladder - any luck?
Think the goalposts are being shifted with this and we will have to wait for final positioning by FDA. It looks as if there is an attempt to get everything under the fda umbrella .Full Cms approval would follow in quick succession by the sound of whats happened with Exact.
Some of the warnings with using the kit are a bit weird.
Possible hand strain opening and closing the lid on the box?
What are they using, Gorilla Glue? Guess they dont want to come unstuck.:)

Tried the search and got some hits but they were all things with cx in other contexts and various uses of the word bladder--I couldnt find CX Bladder anywhere--am I missing something?

[Minerbarejet]

maybe so..but I have certainly not misunderstood that nothing has been said about CX on any of the cancer or medical sites Ive been searching in the US--Have you had any better luck?
Have you looked on Inspire, Bladder Cancer Advocacy Network.

[AndyLP]

maybe so..but I have certainly not misunderstood that nothing has been said about CX on any of the cancer or medical sites Ive been searching in the US--Have you had any better luck?

Blue Cross / Blue Sheild are definitely aware of cxBladder.
Its mentioned - albeit briefly - here: https://www.bcbsnc.com/assets/services/public/pdfs/medicalpolicy/urinary_tumor_markers_for_bladder_cancer.pdf
Have a look under the "Urinary Tumor Markers for Bladder Cancer"
Also mentions that at the time of writing, cxBladder is not approved by the FDA

[Minerbarejet]

Blue Cross / Blue Sheild are definitely aware of cxBladder.
Its mentioned - albeit briefly - here: https://www.bcbsnc.com/assets/services/public/pdfs/medicalpolicy/urinary_tumor_markers_for_bladder_cancer.pdf
Have a look under the "Urinary Tumor Markers for Bladder Cancer"
Also mentions that at the time of writing, cxBladder is not approved by the FDA
And in addition that reviews would be carried out by BC/BS every six months.
Various States have also approved the construction of the lab for PEDUSA and issued certificates. They must know what it was for.

[Minerbarejet]

Tried the search and got some hits but they were all things with cx in other contexts and various uses of the word bladder--I couldnt find CX Bladder anywhere--am I missing something?
Thats what I ran into as well on that FDA site, "we haven't heard of it so far". Why not? Because cxBladder, being an LDT, has not been required to have our approval to operate, therefore, its not in the FDA system. This is what is about to change apparently, hence the delay while things are sorted. Maybe PEB can get into the parallel experiment, would seem to be a similar candidate to Exact.
Found it interesting that although FDA approved the product they only said it could be used, not that it was recommended as a replacement for the current process.
Makes you think though, 17.00 a share for Exact and not even recommended as mainstream.

[Minerbarejet]

Speak of the devil. Pacific Edge Alert on Google comes up with this this morning.
A Licence to operate the lab in Pennsylvania
https://www.google.com/url?rct=j&sa=t&url=http://www.pacificedgedx.com/assets/assets/PA-License-2014-2015.pdf&ct=ga&cd=CAEYACoTNTAxNjc3MTUwNjA2MDI0NDg2MDIcZjVkNzEzNDR mZmYwZDI1Mjpjby5uejplbjpOWg&usg=AFQjCNFI72hZ1mHTurOM1_87fJDWUvRZpA

[MAC]

Seems to be plenty of exposure for Cxbladder online for a product that’s in its first year of commercialisation, should be quite a lot more after five years.

It would be interesting to ask Jackie Walker if Pacific Edge should pursue FDA approval, understanding that it’s not necessary, but just because it may be one less matter for the sales folk to clarify when door knocking, and the FDA do seem to want to head in that direction also. Such things can do no harm.

[Balance]

Meow?

Chairman Swann better have a good explanation at the AGM.

[MAC]

Meow?

Chairman Swann better have a good explanation at the AGM.

A good explanation for ???

[sharp]

A good explanation for ???

Volatility in the SP today?

[sharp]

Disclosure. I bought in today.

[MAC]

I hardly think the company chairman need explain himself for what short term traders do or don't do ?

[Bobcat.]

Looking today to see a knee bounce off 64c - and so have a bid on market accordingly. It could bounce off its current price of 65c but I'm picking a bit more volume than 750k is required for a pivot and momentum shift. When it dropped to 69c last June, we saw 2m traded.

If I'm wrong and it weakens further (which is unusual just before an AGM) we could see it bounce off a double bottom at 62c. Either way, with a stop loss at 61c, I can mitigate the risk well enough at these prices. More potential upside now IMO than anything more serious coming over the next few weeks that might continue the downward pressure of late. The AGM next Thursday may well have a pleasant surprise re Sales progress in the US.

Trading accordingly.

BC

[Balance]

I hardly think the company chairman need explain himself for what short term traders do or don't do ?

Haha - definitely no.

Chairman will be questioned by a really pissed off shareholder about his 'tens of thousands' of tests comment.

[sharp]

Looking today to see a knee bounce off 64c - and so have a bid on market accordingly. It could bounce off its current price of 65c but I'm picking a bit more volume than 750k is required for a pivot and momentum shift. When it dropped to 69c last June, we saw 2m traded.

If I'm wrong and it weakens further (which is unusual just before an AGM) we could see it bounce off a double bottom at 62c. Either way, with a stop loss at 61c, I can mitigate the risk well enough at these prices. More potential upside now IMO than anything more serious coming over the next few weeks that might continue the downward pressure of late. The AGM next Thursday may well have a pleasant surprise re Sales progress in the US.

Trading accordingly.

BC

I too have taken the same approach. I am truly "well" invested with PEB thanks to the sell-off today.

My opinion is that it is not unusual to see some volatility before an AGM.

[nextbigthing]

Looks like they're not finished unloading just yet...

[skid]

Seems to be plenty of exposure for Cxbladder online for a product that’s in its first year of commercialisation, should be quite a lot more after five years.

It would be interesting to ask Jackie Walker if Pacific Edge should pursue FDA approval, understanding that it’s not necessary, but just because it may be one less matter for the sales folk to clarify when door knocking, and the FDA do seem to want to head in that direction also. Such things can do no harm.

Didnt realize it wasnt necessary for FDA approval--my mistake----but where is all the exposure you mention?
Maybe Im just not looking in the right places. 9Im assuming your talking about USA.

[sharp]

Looks like they're not finished unloading just yet...

ForBar will no doubt picking up on some of the sell-off if they follow their analyst's report on PEB.

[MAC]

knock, knock, knock, knock, knock, knock, knock, knock, knock

For the benefit of any whom may be mislead, although I really do doubt many take any notice of knockers;

Pacific Edge do not have FDA approval because the FDA do not provide approvals unless a biotech company operates laboratories in more than one state, or if the test activity is performed outside of a laboratory potentially across multiple states, eg: a test that can be performed at home, potentially anywhere.

Pacific Edge are required to have CLIA approvals, which they do have, as administered and provided by CMS.

The FDA does though develop rules and provides guidance for CLIA.

Unlike knockers, US insurers know what FDA, CLIA, and LDT mean.

[Wolf]

Seller at 0.65 keeps reloading decent blocks. Someone offloading?

[nextbigthing]

knock, knock, knock, knock, knock, knock, knock, knock, knock

For the benefit of any whom may be mislead, although I really do doubt many take any notice of knockers;

Pacific Edge do not have FDA approval because the FDA do not provide approvals unless a biotech company operates laboratories in more than one state, or if the test activity is performed outside of a laboratory potentially across multiple states, eg: a test that can be performed at home, potentially anywhere.

Pacific Edge are required to have CLIA approvals, which they do have, as administered and provided by CMS.

The FDA does though develop rules and provides guidance for CLIA.

Unlike knockers, US insurers know what FDA, CLIA, and LDT mean.

MAC, does that mean that they won't be able to roll out the 'direct to the customer' internet option in the US without FDA approval then?

Disc) Some in holding portfolio, some in trading portfolio :)

[nextbigthing]

knock, knock, knock, knock, knock, knock, knock, knock, knock


Who's there? :)

[MAC]

MAC, does that mean that they won't be able to roll out the 'direct to the customer' internet option in the US without FDA approval then?

Disc) Some in holding portfolio, some in trading portfolio :)

Not sure what the reason might be Nextbigthing, could just be a bit early in the US yet, or perhaps they would prefer to talk to the Urologists when they order still for now.

Provided PEB only perform the tests in a single laboratory, I don't think it matters where they sell to or where the sample kits get sent to in the US, or how they are ordered, directly or on the internet, unless there is some specific regulations covering what can or cannot be ordered online, not sure about that one.

[okay]

Stalin: Knock, knock
Comrade: Who's there?
Stalin: I ASK THE QUESTIONS!!!!

What was Stalins only hit single?
Every breath you take I'll be watching you.

Courtesy the late Robin Williams...

[Minerbarejet]

MAC, does that mean that they won't be able to roll out the 'direct to the customer' internet option in the US without FDA approval then?

Disc) Some in holding portfolio, some in trading portfolio :)Yep. Might sprain their wrist opening the box.
Disc:))me too
Cheers
Miner

[MAC]

Haha - definitely no.

Chairman will be questioned by a really pissed off shareholder about his 'tens of thousands' of tests comment.

I think they would get more out of a new pair of glasses :)


I don’t know Moosie, everybody has a unique way of analysing and some have more business exp than others to draw on. That now infamous quote, whether it was actually said or was not said;

“The Pennsylvania lab has the capacity to process 260,000 tests a year and Mr Swann is confident the company will processing ''several tens of thousands of tests'' next year.” (http://www.odt.co.nz/news/business/286676/pacific-edge-business)

I’ve always interpreted that as this present calendar year, others may interpret it as sales to the FY15 financial year reporting. Either way we will not know if they have achieved what was published until May 2015 when the preliminary results are due.

If individuals anticipated 10,000+ sales to FY14 from such comments, then I guess firstly, they cannot read the words “next” and “tests”, and secondly they need to do more investment research, a company cannot substantively sell without first hiring a sales force.

My view is that 10,000+ tests is entirely probable by FY15, I would always as an investor hope that we get some numerical guidance from this AGM but don’t expect it for the same reasons as last year.

[Balance]

I think they would get more out of a new pair of glasses :)

This is on the record and uncorrected by Mr Swann or PEB to date :

"The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11178639

Not 'next year' but '2014'.

[MAC]

This is on the record and uncorrected by Mr Swann or PEB to date :

"The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11178639

Not 'next year' but '2014'.

Yep, and we should know in May 2015 at reporting time if he was right.

Companies don't generally provide YTD sales figures at AGM's, Pacific Edge won't either.

[nextbigthing]

How long does FDA approval typically take for this sort of product?

[Balance]

Yep, and we should know in May 2015 at reporting time if he was right.

Companies don't generally provide YTD sales figures at AGM's, Pacific Edge won't either.

As he made the comment without prompting and given Mr Chris Swann sold shares on the back of his comments, shareholders and the market are entitled to an update.

[okay]

Snapiti, any details on the testing numbers submitted by nmp22 for FDA approval?
Per psychics link I see Exact Sciences did in excess of 10000.
"The safety and effectiveness of Cologuard was established in a clinical trial that screened 10,023 subjects."

[Minerbarejet]

This is on the record and uncorrected by Mr Swann or PEB to date :

"The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11178639

Not 'next year' but '2014'.This is what the reporter wrote, not what Mr Swann said. Big difference.

[nextbigthing]

This is what the reporter wrote, not what Mr Swann said. Big difference.

I wonder if the same reporter will be covering the AGM? Would be nice to have them both in the same room...

[Minerbarejet]

I wonder if the same reporter will be covering the AGM? Would be nice to have them both in the same room...
We can only dream.:)

[psychic]

Skid whilst mac is technically right..... medically cx bladder does not need FDA approval to be used by clinicians what he either fails to understand or does not want to mention is many US health insurance companies will not cover products that are not FDA approved. I believe this is why nmp22(cx bladders main rival test) has gone down that path and is FDA approved.
As we all know if an insurance company can use a loophole to get out of paying they will.
I believe this is an oversight by the company.

Snapiti. Re - the bit in bold. Is this just your opinion,or do you have something you can cite?

[psychic]

Anyone considering an investment in PEB should do their home work on what many health insurers in the US don't cover.
Fact 1. Many health insurance policies clearly state that insurers will not cover products that do not have FDA approval.
Fact 2. NMP22 bio marker developers applied for and received FDA approval prior to the commercial launch of their product in the US..... refer to fact 1 to understand why they did this.

Oh, then saw this later post of yours. So you can cite somehow?These are FACTS now?

Thats it, we are stuffed then. Even though Cxbladder will save them millions. Bugger.

[ghostrider68]

im in at 65cents. these are a steal at that price I reckon

[psychic]

it is fact not just opinion.
I first stumpled onto it on a blog through the American cancer society.
It was mentioned by many bloggers how pissed they were at their health insurance providers hiding behind a loophole when it came to not covering cancer diagnostics that were not FDA approved.(not just bladder cancer)
It was obvious from reading the blogs that many insurance companies were taking this stance.
I just followed the links provided from the bloggers some of these links went straight to their health insurance providers policies and documents..... the wording in most of these insurance policies was very clear about not covering cancer diagnostics that did not have FDA approval.
Take what you like from this info..... call me a knocker but most of all feel free to do your own research..... I have hours of it..... actually probably days on this stock and thanks to that research I sold out for a very nice 117% profit and are now waiting to see if they can gain sales traction before reinvesting.
I am sure PEB have learnt enough from failing in NZ, EUROPE, SPAIN and AUS not to be stupid enough to enter another market without knowing the right passage to create sales traction.
Opp's more facts that the PEB bulls don't want to hear.:)


Right, so you can't cite anything.

My "opinion" is that they will likely follow the lead of CMS and best practice - with or without FDA approval.

[Balance]

This is what the reporter wrote, not what Mr Swann said. Big difference.

He said it in Dec 2013 - so next year or 2014 are the same thing, surely?

Point is - PEB or Mr Swann (experienced director) did not correct the reporter. There is a world of difference between a few hundred tests versus tens of thousands of tests!

[Minerbarejet]

He said it in Dec 2013 - so next year or 2014 are the same thing, surely?

Point is - PEB or Mr Swann (experienced director) did not correct the reporter. There is a world of difference between a few hundred tests versus tens of thousands of tests!You are quite right Balance, one would think that was what was meant at that time,
however people do sometimes get ahead of themselves especially late in the year. It still doesnt alter the fact it was reported that way by the reporter- it was not an announcement from the company or Swann. Who would you rather have running PEB- Swann or the Otago Daily Times. ODT have always been very parochial and enthusiastic about Pacific Edge given they are both Dunedin based and obviously this is something that has not really worked to anyones advantage in this instance. Anyone investing in PEB solely on the basis of what is reported in the ODT amidst a background of enthusiastic clamour may be interested in seeking some financial advice from elsewhere on the matter during the next cycle of hyperbole
Dont worry, Balance, it will all get sorted out in the end.

[goldfish]

Some very interesting share trading today @ 65 cents with an iceberg being parted out to what looked like a bot buyer. Interested in why they didn't dark pool trade it. Most likely Westpac/Salt picking up more for a trade...

I got some for a quick trade when it first hit 65, looked like there was one seller who sold down from 69 to 65 in one lot then hit any buyers at 65 for the rest of the day. Hopefully they have finished and itll bounce back up tomorrow, if not im in no hurry I dont think itll go under 60, any time before it bounces closer to 70. If it does it will hit my stop loss.

[Goldstein]

Guys, I'm not sure I quite agree. If you were the director of a company and the share price rocketed to what you thought the company would be worth in three years time, then would you sell some of the shares you own?

It's a pretty serious accusation to say a director misled the media to ramp up the share price.

Remember, a director of a fledgling company is always going to sound upbeat.

[nextbigthing]

Goldstein you're right, I very highly doubt it was deliberately done. However I do believe the situation was taken advantage of when it should have been cleared up instead. That's almost as bad.

[Xerof]

Did anyone else read my post

nah, we've all got you on ignore moosie



:p

[nextbigthing]

Did anyone else read my post...

Nope. You post so much Moosie, we can't get through it all so it's easier just to skip them.


Doing some simple math (including paid and unpaid tests), the Moosie calculator comes up with a figure just shy of that magic 10K mark...

This calculator has a dubious record.


Just kidding Moosie :D


Edit; Have just seen Xerofs post, great minds think alike.

[Minerbarejet]

Did anyone else read my post..
Moosie, you dont believe that people actually read this stuff do you?:scared:

[Minerbarejet]

That is an amazing Moosie calculator, especially since it has pluck from arse and hindsight keys!
Must have a foresight key as well as he has answered your post before you wrote it. ???????
Any bets moosie bought back in yesterday at 65?:)

[MAC]

He said it in Dec 2013 - so next year or 2014 are the same thing, surely?

Point is - PEB or Mr Swann (experienced director) did not correct the reporter. There is a world of difference between a few hundred tests versus tens of thousands of tests!

And, ..... we will all know in May 2015 at FY15 reporting time if there have been 10,000+ tests accrued to the end of 2014 or not.

Chris Swan is very probably entirely correct, whether he said it or not, and thus that is probably why no media correction was forth coming.

I don’t see that he has to account to anyone whatsoever, let alone to a bunch of short term traders who didn't get to make a quick buck.

Good on him for selling a few shares too after years of hard work, well done to him I say.

[Balance]

I don’t see that he has to account to anyone whatsoever, let alone to a bunch of short term traders who didn't get to make a quick buck.

Good on him for selling a few shares too after years of hard work, well done to him I say.

Well, that tells us all a lot about your expectations of the directors who are supposed to represent all shareholders' interest in a company!

FYI, I have been a shareholder (and still am) since the sp was 28 cents. Like Hancocks, I still believe in the potential of CxBladder and in inference, the future of PEB.

I do not and will not allow the Chairman of any company to make public comments without being accountable for those comments.

PEB and Mr Swann obviously have a lot to learn and being arrogant and slippery are two characteristics they have to discard quickly.

[MAC]

Well, that tells us all a lot about your expectations of the directors who are supposed to represent all shareholders' interest in a company!

FYI, I have been a shareholder (and still am) since the sp was 28 cents. Like Hancocks, I still believe in the potential of CxBladder and in inference, the future of PEB.

I do not and will not allow the Chairman of any company to make public comments without being accountable for those comments.

PEB and Mr Swann obviously have a lot to learn and being arrogant and slippery are two characteristics they have to discard quickly.

The only arrogance I'm seeing is from few posters on this forum with a vocal minority view who don’t represent the predominance of content shareholders comfortable with the progress the company has made in the last year.

As a chairman who is positive about his company, as most are, he should be setting goals and targets for his people to aim for and to deliver on, that’s not arrogant, that's expected of a good chairman.

It is entirely most likely there was no retraction, if indeed he did not provide the comments, simply because the comments are probably very close to what Pacific Edge anticipate will occur this year.

As in December last year when he was about to start hiring and training a sales force of 20 (presently at 12 now already), it was entirely appropriate to offer a fair anticipation of what they may deliver from that time forward.

[nextbigthing]

When questioned he wasn't willing to back those comments up. After he had sold. Just saying.

[Balance]

The only arrogance I'm seeing is from few posters on this forum with a vocal minority view who don’t represent the predominance of content shareholders comfortable with the progress the company has made in the last year.



1. If it is consistent with PEB's anticipates, then as PEB's spokesman he has articulated to the market - why is he not backing it up or updating the market now?

2. His comments led directly to the sp spiking upwards - after which he sold. As Chairman of PEB, he has to be cleaner than clean.

As for vocal minority, the sp tells you that it ain't no vocal minority who are questioning the company and its management.

Luckily the market does not consist of armchair investors who sheepishly accept whatever a company tells them.

Pike River and Rakon are two prime examples of shareholders who think the sun shone out of the proverbial of the directors and management.

Mr Swann better explain his comments at the AGM - there are ways of making him talk, as they say. :D

[MAC]

1. If it is consistent with PEB's anticipates, then as PEB's spokesman he has articulated to the market - why is he not backing it up now?

2. His comments led directly to the sp spiking upwards - after which he sold. As Chairman of PEB, he has to be cleaner than clean.

As for vocal minority, the sp tells you that it ain't no vocal minority who are questioning the company and its management.

Luckily the market does not consist of armchair investors who sheepishly accept whatever a company tells them.

Pike River and Rakon are two prime examples of shareholders who think the sun shone out of the proverbial.

1. It's not any company's job to continually back comments up, others don’t, just like any other company Pacific Edge have better things to do then to pander, like research and training sales staff.

2. The SP is/was evidentially following a correlation with XRO, very little to do with what anyone said or didn't say. If you want someone to blame for the volatility you should ask which traders they are.

We shall see on the 21st, I'm anticipating that Chris Swan will be given an overwhelming endorsement and re-elected, he gets my vote and I’m anticipating he will probably get the vote of most shareholders. Lot's of good progress made this year by all the good folk at Pacific Edge under his stewardship.

Just because a bunch of traders like volatility and big SP swings, doesn't mean it reflects one bit on all the good effort and work Pacific Edge have achieved over the last year. Growth stocks are inherently volatile.

Lucky the sharemarket does not totally consist of paranoid, conspiracy theory developing knockers, no companies would ever list.

[Bobcat.]

I've been watching the trading on PEB these past few days (you'd think I'd have something better to do!) and have noticed that the very large seller at 65c is very persistent, and clearly has not finished selling. Just when I thought he was being outmatched by a bidder wanting 100k, that bid was snapped up within 5 mins, and again a 25k parcel sits at 65c as bait.

The quarter Scotsman in me would rather get it at 64, and so there my bid remains...I would say that once the seller finishes, we will see a lift in price through to next week's AGM where hopefully some good news (concrete rather than rhetoric) will boost it higher still.

Trading to it.

BC.

[Balance]

1. It's not any company's job to continually back comments up, others don’t, just like any other company Pacific Edge have better things to do then to pander, like research and training sales staff.

2. The SP is/was evidentially following a correlation with XRO, very little to do with what anyone said or didn't say. If you want someone to blame for the volatility you should ask which traders they are.

We shall see on the 21st, I'm anticipating that Chris Swan will be given an overwhelming endorsement and re-elected, he gets my vote and I’m anticipating he will probably get the vote of most shareholders. Lot's of good progress made this year by all the good folk at Pacific Edge under his stewardship.

Just because a bunch of traders like volatility and big SP swings, doesn't mean it reflects one bit on all the good effort and work Pacific Edge have achieved over the last year. Growth stocks are inherently volatile.

Lucky the sharemarket does not totally consist of paranoid, conspiracy theory developing knockers, no companies would ever list.

MAC, believe me when I write that Mr Swann better front up at the AGM and addresses his 'tens of thousands of tests' comment. .

Nothing to do with trading or conspiracy theories - it is called continuous disclosure. It is about an even playing field for all shareholders.

It is simply unacceptable for the Chairman of a company like PEB to make that kind of comment, pump up the hype, sell shares and then, pretend he never said anything.

Meanwhile, note that less than 5,000 tests are forecast for the July 2014 to June 2015 year by one of the major brokers in their report on PEB. The report was prepared after extensive discussions with the company.

[winner69]

Those investors who commissioned that Edison report must be getting impatient

Good if it came out before the AGM with the expected $1.40 to $1.70 valuation

[MAC]

One can not be held accountable Balance for an estimate for which the outcome will not be known until next year, either way an estimate is just that, made fairly without the full benefit of time travel.

He is accountable though for lots of things he can report on, successfully signing up four network providers, proudly achieving CLIA accreditation for the NZ lab, first commercial sales made, progressively ramping up sales staff, bringing in all those new directors and senior managers on board with all that experience, etc, etc, etc, yes, accountable indeed.

If a bitter and twisted individual does wish to stand up at question time, well it will be entertaining, best have their case facts straight though, well if they actually have a case, I can’t see one in this instance.

[Balance]

One can not be held accountable Balance for an estimate for which the outcome will not be known until next year, either way an estimate is just that, made fairly without the full benefit of time travel.

He is accountable though for lots of things he can report on, successfully signing up four network providers, proudly achieving CLIA accreditation for the NZ lab, first commercial sales made, progressively ramping up sales staff, bringing in all those new directors and senior managers on board with all that experience, etc, etc, etc, yes, accountable indeed.

If a bitter and twisted individual does wish to stand up at question time, well it will be entertaining, best have their case facts straight though, well if they actually have a case, I can’t see one in this instance.

MAC, holding a director or a company accountable is not bitter or twisted. It is about ensuring the highest level of corporate governance for the benefit of ALL shareholders.

[nextbigthing]

Wonder how much more this seller has to get through. Hopefully they don't drop sub 65c!

[Goldstein]

MAC, believe me when I write that Mr Swann better front up at the AGM and addresses his 'tens of thousands of tests' comment. .

Nothing to do with trading or conspiracy theories - it is called continuous disclosure. It is about an even playing field for all shareholders.

It is simply unacceptable for the Chairman of a company like PEB to make that kind of comment, pump up the hype, sell shares and then, pretend he never said anything.

Meanwhile, note that less than 5,000 tests are forecast for the July 2014 to June 2015 year by one of the major brokers in their report on PEB. The report was prepared after extensive discussions with the company.

Balance, I agree with your continuous disclosure comment. All this 'who said what to whom' would go away if they started disclosing how the products were tracking. Even a quarterly note would do.

With no information it just feels like a gamble to me.

[Bobcat.]

MAC, holding a director or a company accountable is not bitter or twisted. It is about ensuring the highest level of corporate governance for the benefit of ALL shareholders.

I agree. Nonetheless, there has been some bitterness expressed on this thread...and one should be careful not to let it taint an otherwise civilised approach (e.g. during question time at the AGM). We would be wise to heed the warning stated in Heb 12:15...

"Looking diligently, lest any “root of bitterness” springs up and causes trouble, and by it many become defiled".

Besides, bitterness is a toxin that we tend to prepare for someone else...but then drink ourselves!

Successful investors and traders do not their emotions get the better of them. It's unhealthy and unprofitable to do so.

[geo]

im in at 65cents. these are a steal at that price I reckon


Really can you please enlighten us why you think they are a steal?

[Balance]

I agree. Nonetheless, there has been some bitterness expressed on this thread...and one should be careful not to let it taint an otherwise civilised approach (e.g. during question time at the AGM). We would be wise to heed the warning stated in Heb 12:15...

"Looking diligently, lest any “root of bitterness” springs up and causes trouble, and by it many become defiled".

Besides, bitterness is a toxin that we tend to prepare for someone else...but then drink ourselves!

Successful investors and traders do not their emotions get the better of them. It's unhealthy and unprofitable to do so.

Words of wisdom indeed.

I can understand bitterness from anyone who bought on the back of Mr Swann's comment. I certainly did not but I believe very strongly in good corporate governance.

And of course I prefer as a shareholder for the sp to be $1 than 65 cents!

[MAC]

MAC, holding a director or a company accountable is not bitter or twisted. It is about ensuring the highest level of corporate governance for the benefit of ALL shareholders.

All directors are accountable for company performance and their actions, but accountable for the imaginings and conspiracy theories of bitter and twisted knockers, ... not so much.

Chris Swan didn’t make knockers misread a newspaper for which he may or may not have provided a comment, he’s hardly accountable for that.

Expressing bitter and twisted emotions at a professionally provided annual general meeting is unlikely to influence anyone, particularly if it is just some individual’s conjured perception of an issue that does not really exist.

But, every shareholder has the right to stand up, state their name and have a go, it would be entertaining.

[Balance]

Chris Swan didn’t make knockers misread a newspaper for which he may or may not have provided a comment, he’s hardly accountable for that.



Mac, please explain then your interpretation of what Mr Swann said then?

" The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

[Goldstein]

All directors are accountable for company performance and their actions, but accountable for the imaginings and conspiracy theories of bitter and twisted knockers, ... not so much.

Chris Swan didn’t make knockers misread a newspaper for which he may or may not have provided a comment, he’s hardly accountable for that.

Expressing bitter and twisted emotions at a professionally provided annual general meeting is unlikely to influence anyone, particularly if it is just some individual’s conjured perception of an issue that does not really exist.

But, every shareholder has the right to stand up, state their name and have a go, it would be entertaining.

When you put it like that MAC it sounds like the 65c admission fee is worth it. :)

[MAC]

Mac, please explain then your interpretation of what Mr Swann said then?

" The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

It is really not a difficult comprehension Balance.

The Pennsylvania lab has the capacity to process 260,000 tests a year and Mr Swann is confident the company will processing ''several tens of thousands of tests'' next year.

http://www.odt.co.nz/news/business/286676/pacific-edge-business

A company tells us that they intend to hire a US sales force, intend to perform several mini user programmes in the US, and provides an estimate of how many associated tests are likely possible over the coming year.

At no time, whether he actually said it or not, did his comment directly relate to sales or to revenues, although IMO based on other research, 10,000+tests achieved by 31 December 2014 is an entirely plausible outcome.

[Balance]

http://en.m.wikipedia.org/wiki/Blind_men_and_an_elephant

Now Moosie, cut that out.

You have one with a moose though?

Haha :D

[Schrodinger]

I can shift goalposts too if I need to stretch a story out. Isnt everyone else doing its so it ok now?

The one thing that really gets me about this "stock" is the $200M cap which is rediculous. Basically the market is factoring in a near sure thing. It was even more silly when it was above $500M.

[Dentie]

I can shift goalposts too if I need to stretch a story out. Isnt everyone else doing its so it ok now?

The one thing that really gets me about this "stock" is the $200M cap which is rediculous. Basically the market is factoring in a near sure thing. It was even more silly when it was above $500M.

You mean the same like XRO's valuation Schrodinger?

Mr Market didn't say he/she knew what he was doing...

[skid]

I too have bought in a modest holding @.65.
Im not going to join the ''high five ,back slapping club'' but I do think that we are now in the territory where i feel I can give them the benefit of the doubt on these issues raised.
Im not expecting miracles but am hoping for slow growth and the appointment of some knowledgeable directors to help things along.

[klid]

Interesting u guys all bought. Headwinds on tech stocks esp xro sli geo today good to see peb not following like it seems to. Xro are not doing well and it WILL continue.... will peb follow? !i think it shouldnt and things should diverge but...

[nextbigthing]

You class PEB as a tech stock? I would've thought it sufficiently different, however for investing purposes you reckon it's close enough?

[Tsuba]

Entertainment plus next Thursday. :)

[klid]

You class PEB as a tech stock? I would've thought it sufficiently different, however for investing purposes you reckon it's close enough?
As I have ranted on about before: this stock follows XRO... WAY TOO closely. Are their fates so tied?

[Minerbarejet]

I too have bought in a modest holding @.65.
Im not going to join the ''high five ,back slapping club'' but I do think that we are now in the territory where i feel I can give them the benefit of the doubt on these issues raised.
Im not expecting miracles but am hoping for slow growth and the appointment of some knowledgeable directors to help things along.Good on you mate, I hope they do well for you.
Also well said on the benefit of the doubt. If the reporter cant even get the sentence right how would we verify the accuracy of the statement. The word (be) is missing.
Obvious question: What else is missing for starters.:)

[Carpenterjoe]

Mac, please explain then your interpretation of what Mr Swann said then?

" The Pennsylvania lab has the capacity to process 260,000 tests a year and Swann is confident the company will be processing "several tens of thousands of tests" during 2014."

Ummmmmm, so he got it wrong whoops, move on.
I remember an interview with David darling stating that he was surprised at the current increase in the share price. If that isn't a message.

Balance, its in the past. You should be asking what Chris can offer, I see your cons list, but show me your pros list.

Maybe he's not good enough, but don't hold somebody accountable for their positive frame of mind.

What's up with people searching so hard for the dark side In people. Have a little trust.

[psychic]

I'm with you mate. I'm invested because these guys are not so polished. It's good kiwi stuff from Otago, taking it to the World. Think this lost on a few lately.

[Schrodinger]

I'm with you mate. I'm invested because these guys are not so polished. It's good kiwi stuff from Otago, taking it to the World. Think this lost on a few lately.

How does taking it from Otago to the world get Americans to buy it? They dont give a rats about Otago or NZ.

I know you mean to say I support Otago business and thats nice. But removing the "cool to back a kiwi" from the investment what exactly is going to cause this company to scale. That should be your prime investment decision.

[psychic]

How does taking it from Otago to the world get Americans to buy it? They dont give a rats about Otago or NZ.

I know you mean to say I support Otago business and thats nice. But removing the "cool to back a kiwi" from the investment what exactly is going to cause this company to scale. That should be your prime investment decision.

Cxbladder for one